Evidence	O
for	O
repression	O
of	O
IL-2	B-DNA
gene	I-DNA
activation	O
in	O
anergic	B-cell_type
T	I-cell_type
cells	I-cell_type
.	O

The	O
induction	O
of	O
clonal	O
anergy	O
in	O
a	O
T	O
cell	O
inhibits	O
IL-2	B-protein
secretion	O
because	O
of	O
the	O
development	O
of	O
a	O
proximal	O
signal	O
transduction	O
defect	O
.	O

Fusion	O
of	O
anergic	B-cell_type
murine	I-cell_type
T	I-cell_type
cells	I-cell_type
to	O
human	B-cell_type
Jurkat	I-cell_type
T	I-cell_type
leukemia	I-cell_type
cells	I-cell_type
and	O
formation	O
of	O
heterokaryons	B-cell_line
failed	O
to	O
result	O
in	O
a	O
complementation	O
of	O
this	O
signaling	O
defect	O
and	O
restoration	O
of	O
murine	B-RNA
IL-2	I-RNA
mRNA	I-RNA
inducibility	O
.	O

Instead	O
,	O
signal	O
transduction	O
to	O
the	O
human	O
IL-2	B-DNA
gene	I-DNA
became	O
disrupted	O
.	O

Heterokaryons	B-cell_line
formed	O
by	O
the	O
fusion	O
of	O
anergic	B-cell_type
murine	I-cell_type
T	I-cell_type
cells	I-cell_type
to	O
normal	B-cell_type
murine	I-cell_type
T	I-cell_type
cells	I-cell_type
also	O
failed	O
to	O
accumulate	O
intracellular	B-protein
IL-2	I-protein
protein	I-protein
in	O
response	O
to	O
stimulation	O
either	O
with	O
the	O
combination	O
of	O
CD3	B-protein
and	O
CD28	B-protein
mAbs	I-protein
or	O
with	O
ionomycin	O
plus	O
a	O
protein	B-protein
kinase	I-protein
C	I-protein
-activating	O
phorbol	O
ester	O
.	O

The	O
results	O
argue	O
against	O
a	O
loss-of-function	O
signaling	O
defect	O
as	O
the	O
sole	O
basis	O
for	O
clonal	O
anergy	O
induction	O
and	O
document	O
the	O
presence	O
of	O
a	O
dominant-acting	B-protein
repressor	I-protein
molecule	I-protein
that	O
inhibits	O
signal	O
transduction	O
to	O
the	O
IL-2	B-DNA
gene	I-DNA
within	O
viable	O
anergic	B-cell_type
T	I-cell_type
cells	I-cell_type
.	O

Accelerating	NULL
Life	NULL
Sciences	NULL
.	NULL

2	NULL
nozzles	NULL
per	NULL
well	NULL
enable	NULL
cell	NULL
Cha	NULL
Check	NULL
out	NULL
how	NULL
Laminar	NULL
Wash	NULL
l	NULL
washing	NULL
by	NULL
creating	NULL
a	NULL
laminar	NULL
T	NULL
‘	NULL
.CU	NULL
RIOX	NULL
systems	NULL
replace	NULL
centrifugation	NULL
completely	NULL
in	NULL
handling	NULL
cells	NULL
See	NULL
How	NULL
It	NULL
Works	NULL
#	NULL
meJournal	NULL
of	NULL
Evidence	NULL
for	NULL
Repression	NULL
of	NULL
IL-2	NULL
Gene	NULL
4D	NULL
Imnmunolo	NULL
gy	NULL
Activation	NULL
in	NULL
Anergic	NULL
T	NULL
Cells	NULL
David	NULL
G.	NULL
Telander	NULL
,	NULL
Erika-Nell	NULL
Malvey	NULL
and	NULL
Daniel	NULL
L.	NULL
Mueller	NULL
This	NULL
information	NULL
is	NULL
current	NULL
a	NULL
$	NULL
_	NULL
J	NULL
ppuno	NULL
]	NULL
1999	NULL
;	NULL
162:1460-1465	NULL
;	NULL
;	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019.	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/3/1460	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
28	NULL
articles	NULL
,	NULL
21	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/3/1460.full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
Evidence	NULL
for	NULL
Repression	NULL
of	NULL
IL-2	NULL
Gene	NULL
Activation	NULL
in	NULL
Anergic	NULL
T	NULL
Cells	NULL
!	NULL

David	NULL
G.	NULL
Telander	NULL
,	NULL
Erika-Nell	NULL
Malvey	NULL
,	NULL
and	NULL
Daniel	NULL
L.	NULL
Mueller®	NULL
The	NULL
induction	NULL
of	NULL
clonal	NULL
anergy	NULL
in	NULL
a	NULL
T	NULL
cell	NULL
inhibits	NULL
IL-2	NULL
secretion	NULL
because	NULL
of	NULL
the	NULL
development	NULL
of	NULL
a	NULL
proximal	NULL
signal	NULL
transduction	NULL
defect	NULL
.	NULL

Fusion	NULL
of	NULL
anergic	NULL
murine	NULL
T	NULL
cells	NULL
to	NULL
human	NULL
Jurkat	NULL
T	NULL
leukemia	NULL
cells	NULL
and	NULL
formation	NULL
of	NULL
heterokaryons	NULL
failed	NULL
to	NULL
result	NULL
in	NULL
a	NULL
complementation	NULL
of	NULL
this	NULL
signaling	NULL
defect	NULL
and	NULL
restoration	NULL
of	NULL
murine	NULL
IL-2	NULL
mRNA	NULL
inducibility	NULL
.	NULL

Instead	NULL
,	NULL
signal	NULL
transduction	NULL
to	NULL
the	NULL
human	NULL
ZL-2	NULL
gene	NULL
became	NULL
disrupted	NULL
.	NULL

Heterokaryons	NULL
formed	NULL
by	NULL
the	NULL
fusion	NULL
of	NULL
anergic	NULL
murine	NULL
T	NULL
cells	NULL
to	NULL
normal	NULL
murine	NULL
T	NULL
cells	NULL
also	NULL
failed	NULL
to	NULL
accumulate	NULL
intracellular	NULL
IL-2	NULL
protein	NULL
in	NULL
response	NULL
to	NULL
stimulation	NULL
either	NULL
with	NULL
the	NULL
combination	NULL
of	NULL
CD3	NULL
and	NULL
CD28	NULL
mAbs	NULL
or	NULL
with	NULL
ionomycin	NULL
plus	NULL
a	NULL
protein	NULL
kinase	NULL
C-activating	NULL
phorbol	NULL
ester	NULL
.	NULL

The	NULL
results	NULL
argue	NULL
against	NULL
a	NULL
loss-of-function	NULL
signaling	NULL
defect	NULL
as	NULL
the	NULL
sole	NULL
basis	NULL
for	NULL
clonal	NULL
anergy	NULL
induction	NULL
and	NULL
document	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
dominant-acting	NULL
repressor	NULL
molecule	NULL
that	NULL
inhibits	NULL
signal	NULL
transduction	NULL
to	NULL
the	NULL
IL-2	NULL
gene	NULL
within	NULL
viable	NULL
anergic	NULL
T	NULL
cells	NULL
.	NULL

enkins	NULL
and	NULL
Schwartz	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
first	NULL
described	NULL
the	NULL
development	NULL
of	NULL
a	NULL
functional	NULL
unresponsiveness	NULL
(	NULL
now	NULL
termed	NULL
clonal	NULL
anergy	NULL
)	NULL
in	NULL
murine	NULL
CD4	NULL
*	NULL
Th	NULL
cell	NULL
clones	NULL
exposed	NULL
to	NULL
a	NULL
peptide	NULL
Ag	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
costimulatory	NULL
signals	NULL
(	NULL
3	NULL
)	NULL
.	NULL

The	NULL
capacity	NULL
of	NULL
these	NULL
affected	NULL
T	NULL
cells	NULL
to	NULL
proliferate	NULL
in	NULL
response	NULL
to	NULL
subsequent	NULL
exposure	NULL
to	NULL
the	NULL
same	NULL
Ag	NULL
was	NULL
significantly	NULL
impaired	NULL
as	NULL
a	NULL
result	NULL
of	NULL
an	NULL
inability	NULL
to	NULL
secrete	NULL
IL-2	NULL
.	NULL

This	NULL
has	NULL
suggested	NULL
that	NULL
a	NULL
novel	NULL
control	NULL
mechanism	NULL
exists	NULL
to	NULL
regulate	NULL
the	NULL
clonal	NULL
expansion	NULL
of	NULL
self-	NULL
Ag-specific	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
peripheral	NULL
immune	NULL
system	NULL
in	NULL
an	NULL
effort	NULL
to	NULL
maintain	NULL
or	NULL
restore	NULL
immune	NULL
self	NULL
tolerance	NULL
(	NULL
4	NULL
)	NULL
.	NULL

While	NULL
the	NULL
biochemical	NULL
basis	NULL
for	NULL
this	NULL
IL-2	NULL
production	NULL
defect	NULL
remains	NULL
uncertain	NULL
,	NULL
we	NULL
and	NULL
others	NULL
have	NULL
observed	NULL
a	NULL
defect	NULL
in	NULL
the	NULL
coupling	NULL
of	NULL
the	NULL
TCR	NULL
to	NULL
downstream	NULL
p21	NULL
``	NULL
and	NULL
mitogen-activated	NULL
protein	NULL
kinases	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
.	NULL

This	NULL
defect	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
an	NULL
inability	NULL
of	NULL
anergic	NULL
cells	NULL
to	NULL
induce	NULL
activating	NULL
protein-1	NULL
complex	NULL
assembly	NULL
and	NULL
function	NULL
at	NULL
the	NULL
5	NULL
'	NULL
IL-2	NULL
gene	NULL
enhancer	NULL
to	NULL
initiate	NULL
transcription	NULL
(	NULL
7-9	NULL
)	NULL
.	NULL

Such	NULL
a	NULL
proximal	NULL
block	NULL
in	NULL
signal	NULL
transduction	NULL
to	NULL
the	NULL
IL-2	NULL
gene	NULL
could	NULL
be	NULL
due	NULL
to	NULL
the	NULL
inactivation	NULL
or	NULL
degradation	NULL
of	NULL
important	NULL
signaling	NULL
molecules	NULL
in	NULL
the	NULL
plasma	NULL
membrane	NULL
or	NULL
cytosol	NULL
of	NULL
unresponsive	NULL
T	NULL
cells	NULL
.	NULL

Alternatively	NULL
,	NULL
clonal	NULL
anergy	NULL
may	NULL
result	NULL
from	NULL
the	NULL
induction	NULL
(	NULL
or	NULL
overexpression	NULL
)	NULL
of	NULL
molecules	NULL
capable	NULL
of	NULL
inhibiting	NULL
the	NULL
transmission	NULL
of	NULL
signals	NULL
from	NULL
the	NULL
Ag	NULL
receptor	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

To	NULL
test	NULL
the	NULL
first	NULL
hypothesis	NULL
,	NULL
we	NULL
determined	NULL
whether	NULL
fusion	NULL
of	NULL
anergic	NULL
murine	NULL
Th	NULL
cells	NULL
to	NULL
normal	NULL
murine	NULL
or	NULL
human	NULL
T	NULL
cells	NULL
otherwise	NULL
capable	NULL
of	NULL
secreting	NULL
IL-2	NULL
would	NULL
be	NULL
sufficient	NULL
to	NULL
result	NULL
in	NULL
a	NULL
complementation	NULL
of	NULL
the	NULL
anergy	NULL
defect	NULL
and	NULL
the	NULL
restoration	NULL
of	NULL
normal	NULL
IL-2	NULL
gene	NULL
inducibility	NULL
.	NULL

We	NULL
focused	NULL
our	NULL
analysis	NULL
only	NULL
on	NULL
the	NULL
heterokaryons	NULL
that	NULL
infrequently	NULL
formed	NULL
following	NULL
exposure	NULL
to	NULL
polyethylene	NULL
glycol	NULL
Department	NULL
of	NULL
Medicine	NULL
and	NULL
Center	NULL
for	NULL
Immunology	NULL
,	NULL
University	NULL
of	NULL
Minnesota	NULL
Medical	NULL
School	NULL
,	NULL
Minneapolis	NULL
,	NULL
MN	NULL
55455	NULL
Received	NULL
for	NULL
publication	NULL
August	NULL
10	NULL
,	NULL
1998	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
October	NULL
26	NULL
,	NULL
1998	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
Lutheran	NULL
Brotherhood	NULL
predoctoral	NULL
scholarship	NULL
(	NULL
to	NULL
D.G.T	NULL
.	NULL
)	NULL

,	NULL
a	NULL
predoctoral	NULL
training	NULL
grant	NULL
from	NULL
the	NULL
National	NULL
Institute	NULL
of	NULL
Health	NULL
(	NULL
AIO7313	NULL
to	NULL
E.-N.M.	NULL
)	NULL
,	NULL
an	NULL
Investigator	NULL
Award	NULL
from	NULL
the	NULL
National	NULL
Arthritis	NULL
Foundation	NULL
(	NULL
to	NULL
D.L.M	NULL
.	NULL
)	NULL

,	NULL
and	NULL
grants	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
(	NULL
GMS54706	NULL
and	NULL
AI35296	NULL
)	NULL
.	NULL

2	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Daniel	NULL
L.	NULL
Mueller	NULL
,	NULL
Center	NULL
for	NULL
Immunology	NULL
,	NULL
University	NULL
of	NULL
Minnesota	NULL
Medical	NULL
School	NULL
,	NULL
Box	NULL
334	NULL
FUMC	NULL
,	NULL
312	NULL
Church	NULL
St	NULL
.	NULL

S.E	NULL
.	NULL

,	NULL
Room	NULL
6-120	NULL
BSBE	NULL
,	NULL
Minneapolis	NULL
,	NULL
MN	NULL
55455	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
dmuell	NULL
@	NULL
lenti.med.umn.edu	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1999	NULL
,	NULL
162	NULL
;	NULL
1460-1465	NULL
.	NULL

(	NULL
PEG	NULL
)	NULL
both	NULL
by	NULL
using	NULL
a	NULL
strategy	NULL
of	NULL
species-specific	NULL
mAbs	NULL
and	NULL
RT-PCR	NULL
to	NULL
stimulate	NULL
and	NULL
detect	NULL
mRNA	NULL
for	NULL
murine	NULL
IL-2	NULL
and	NULL
by	NULL
detecting	NULL
the	NULL
accumulation	NULL
of	NULL
intracellular	NULL
IL-2	NULL
protein	NULL
in	NULL
heterokaryons	NULL
using	NULL
flow	NULL
cytometry	NULL
.	NULL

Our	NULL
results	NULL
indicate	NULL
that	NULL
a	NULL
molecular	NULL
repressor	NULL
molecule	NULL
present	NULL
within	NULL
anergic	NULL
T	NULL
cells	NULL
can	NULL
block	NULL
the	NULL
transduction	NULL
of	NULL
biochemical	NULL
signals	NULL
from	NULL
the	NULL
plasma	NULL
membrane	NULL
to	NULL
the	NULL
IL-2	NULL
gene	NULL
even	NULL
after	NULL
cell	NULL
fusion	NULL
and	NULL
heterokaryon	NULL
formation	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
T	NULL
cells	NULL
Cloned	NULL
murine	NULL
CD4*	NULL
Th	NULL
cells	NULL
(	NULL
A.E7	NULL
and	NULL
16B.2	NULL
)	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
were	NULL
used	NULL
as	NULL
fusion	NULL
partners	NULL
with	NULL
the	NULL
human	NULL
T	NULL
leukemia	NULL
cell	NULL
line	NULL
Jurkat	NULL
(	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
,	NULL
Manassas	NULL
,	NULL
VA	NULL
)	NULL
.	NULL

A	NULL
murine	NULL
CD4*	NULL
T	NULL
cell	NULL
line	NULL
produced	NULL
by	NULL
intermittent	NULL
in	NULL
vitro	NULL
Ag	NULL
stimulation	NULL
(	NULL
three	NULL
or	NULL
four	NULL
cycles	NULL
)	NULL
of	NULL
lymph	NULL
node	NULL
cells	NULL
from	NULL
the	NULL
DO11.10	NULL
TCR-transgenic	NULL
mice	NULL
was	NULL
also	NULL
used	NULL
in	NULL
the	NULL
murine/	NULL
murine	NULL
heterokaryon	NULL
experiments	NULL
(	NULL
12	NULL
)	NULL
.	NULL

T	NULL
cells	NULL
in	NULL
this	NULL
line	NULL
uniformly	NULL
express	NULL
a	NULL
TCR	NULL
that	NULL
can	NULL
be	NULL
recognized	NULL
by	NULL
the	NULL
KJ1-26	NULL
anti-clonotypic	NULL
mAb	NULL
(	NULL
13	NULL
)	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
grown	NULL
at	NULL
37°C	NULL
with	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
in	NULL
complete	NULL
medium	NULL
consisting	NULL
of	NULL
a	NULL
1/1	NULL
mixture	NULL
of	NULL
Eagle	NULL
's	NULL
Hanks	NULL
'	NULL
amino	NULL
acids	NULL
medium	NULL
(	NULL
Biofluids	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
and	NULL
RPMI	NULL
1640	NULL
(	NULL
Celox	NULL
,	NULL
Hopkins	NULL
,	NULL
MN	NULL
)	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
(	NULL
HyClone	NULL
,	NULL
Logan	NULL
,	NULL
UT	NULL
)	NULL
,	NULL
2	NULL
mM	NULL
L-glutamine	NULL
,	NULL
penicillin	NULL
,	NULL
gentamicin	NULL
,	NULL
and	NULL
5	NULL
X	NULL
10~	NULL
``	NULL
M	NULL
2-ME	NULL
.	NULL

Murine	NULL
cells	NULL
were	NULL
periodically	NULL
stimulated	NULL
with	NULL
irradiated	NULL
syngeneic	NULL
splenocytes	NULL
and	NULL
Ag	NULL
and	NULL
were	NULL
split	NULL
2	NULL
days	NULL
later	NULL
with	NULL
50	NULL
U/ml	NULL
of	NULL
IL-2	NULL
.	NULL

Then	NULL
they	NULL
were	NULL
allowed	NULL
at	NULL
least	NULL
12	NULL
days	NULL
to	NULL
return	NULL
to	NULL
a	NULL
resting	NULL
phenotype	NULL
before	NULL
purification	NULL
on	NULL
Ficoll-Hypaque	NULL
(	NULL
Pharmacia	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
and	NULL
use	NULL
in	NULL
experiments	NULL
.	NULL

Clonal	NULL
anergy	NULL
induction	NULL
Anergy	NULL
was	NULL
induced	NULL
in	NULL
T	NULL
cells	NULL
by	NULL
incubation	NULL
overnight	NULL
at	NULL
37°C	NULL
in	NULL
flasks	NULL
coated	NULL
with	NULL
0.5-2	NULL
ug/ml	NULL
of	NULL
immobilized	NULL
anti-CD3	NULL
mAb	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
accessory	NULL
cells	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Thereafter	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
removed	NULL
from	NULL
the	NULL
mAb	NULL
,	NULL
resuspended	NULL
in	NULL
complete	NULL
medium	NULL
,	NULL
and	NULL
rested	NULL
for	NULL
4-9	NULL
days	NULL
.	NULL

Before	NULL
restimulation	NULL
,	NULL
viable	NULL
cells	NULL
were	NULL
recovered	NULL
on	NULL
a	NULL
Ficoll-Hypague	NULL
density	NULL
gradient	NULL
and	NULL
then	NULL
stimulated	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
experiment	NULL
.	NULL

Heterokaryon	NULL
formation	NULL
Murine	NULL
and	NULL
human	NULL
T	NULL
cells	NULL
were	NULL
mixed	NULL
at	NULL
a	NULL
ratio	NULL
of	NULL
1.5/1	NULL
and	NULL
suspended	NULL
in	NULL
42	NULL
%	NULL
PEG	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
in	NULL
PBS	NULL
for	NULL
2	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
then	NULL
gently	NULL
pelleted	NULL
by	NULL
centrifugation	NULL
at	NULL
1000	NULL
rpm	NULL
for	NULL
5	NULL
min	NULL
(	NULL
14	NULL
)	NULL
.	NULL

PEG	NULL
1000	NULL
proved	NULL
to	NULL
be	NULL
the	NULL
most	NULL
effective	NULL
for	NULL
fusion	NULL
of	NULL
these	NULL
cells	NULL
.	NULL

PEG	NULL
was	NULL
immediately	NULL
washed	NULL
away	NULL
using	NULL
serum-free	NULL
RPMI	NULL
,	NULL
and	NULL
viable	NULL
cells	NULL
were	NULL
recovered	NULL
on	NULL
a	NULL
Ficoll-Hypaque	NULL
centrifugation	NULL
gradient	NULL
.	NULL

3	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
PEG	NULL
,	NULL
polyethylene	NULL
glycol	NULL
;	NULL
Tono	NULL
,	NULL
ionomycin	NULL
;	NULL
HPRT	NULL
,	NULL
hypoxanthine	NULL
phosphoribosyltransferase	NULL
;	NULL
CFSE	NULL
,	NULL
carboxyfluorescein	NULL
diacetate/	NULL
succinimidy	NULL
]	NULL
ester	NULL
;	NULL
MAPK	NULL
,	NULL
mitogen-activated	NULL
protein	NULL
kinase	NULL
.	NULL

0022-1767/99/	NULL
$	NULL
02.00	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
Murine/murine	NULL
heterokaryons	NULL
were	NULL
produced	NULL
in	NULL
a	NULL
similar	NULL
fashion	NULL
after	NULL
mixing	NULL
of	NULL
the	NULL
KJ1-26*	NULL
line	NULL
with	NULL
either	NULL
A.E7	NULL
or	NULL
16B.2	NULL
T	NULL
cells	NULL
at	NULL
a	NULL
1/1	NULL
ratio	NULL
.	NULL

T	NULL
cell	NULL
activation	NULL
T	NULL
cells	NULL
were	NULL
then	NULL
cultivated	NULL
for	NULL
5-7	NULL
h	NULL
in	NULL
complete	NULL
medium	NULL
either	NULL
without	NULL
stimulation	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CD3	NULL
plus	NULL
CD28	NULL
mAbs	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
8	NULL
)	NULL
.	NULL

For	NULL
stimulation	NULL
of	NULL
Jurkat	NULL
cells	NULL
and	NULL
the	NULL
murine/human	NULL
heterokaryons	NULL
,	NULL
purified	NULL
anti-human	NULL
CD3	NULL
mAb	NULL
OKT3	NULL
(	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
)	NULL
or	NULL
64.1	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
Dr.	NULL
Peter	NULL
Lipsky	NULL
,	NULL
University	NULL
of	NULL
Texas	NULL
Southwestern	NULL
Medical	NULL
Center	NULL
,	NULL
Dallas	NULL
,	NULL
TX	NULL
)	NULL
was	NULL
immobilized	NULL
on	NULL
the	NULL
culture	NULL
plate	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
1-10	NULL
pg/ml	NULL
for	NULL
90	NULL
min	NULL
before	NULL
cultivation	NULL
of	NULL
the	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
anti-human	NULL
CD28	NULL
mAb	NULL
9.3	NULL
was	NULL
in	NULL
ascites	NULL
(	NULL
provided	NULL
by	NULL
Dr.	NULL
Jeff	NULL
Ledbetter	NULL
,	NULL
Oncogen	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
)	NULL
and	NULL
was	NULL
added	NULL
directly	NULL
to	NULL
the	NULL
cultures	NULL
at	NULL
a	NULL
1/1000	NULL
dilution	NULL
.	NULL

For	NULL
stimulation	NULL
of	NULL
the	NULL
murine	NULL
T	NULL
cells	NULL
and	NULL
all	NULL
heterokaryons	NULL
,	NULL
purified	NULL
anti-murine	NULL
CD3	NULL
mAb	NULL
145-2C11	NULL
(	NULL
15	NULL
)	NULL
and	NULL
anti-murine	NULL
CD28	NULL
mAb	NULL
37.51	NULL
(	NULL
3	NULL
)	NULL
were	NULL
coimmobilized	NULL
at	NULL
concentrations	NULL
of	NULL
1.0	NULL
and	NULL
0.3	NULL
pg/ml	NULL
,	NULL
respectively	NULL
,	NULL
except	NULL
where	NULL
noted	NULL
.	NULL

Alternatively	NULL
,	NULL
T	NULL
cells	NULL
were	NULL
activated	NULL
with	NULL
the	NULL
combination	NULL
of	NULL
0.5	NULL
uM	NULL
ionomycin	NULL
(	NULL
Iono	NULL
;	NULL
Calbiochem	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
10	NULL
ng/ml	NULL
PMA	NULL
(	NULL
Calbiochem	NULL
)	NULL
to	NULL
bypass	NULL
stimulation	NULL
of	NULL
the	NULL
TCR	NULL
.	NULL

RT-PCR	NULL
Following	NULL
stimulation	NULL
with	NULL
one	NULL
or	NULL
the	NULL
other	NULL
mAb	NULL
pairs	NULL
,	NULL
cultures	NULL
were	NULL
extracted	NULL
with	NULL
RNA-STAT	NULL
60	NULL
(	NULL
Tel-Test	NULL
,	NULL
Friendswood	NULL
,	NULL
TX	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
recommendation	NULL
to	NULL
recover	NULL
total	NULL
cellular	NULL
RNA	NULL
.	NULL

Samples	NULL
were	NULL
DNase	NULL
treated	NULL
,	NULL
and	NULL
5	NULL
pug	NULL
of	NULL
RNA	NULL
was	NULL
then	NULL
reverse	NULL
transcribed	NULL
using	NULL
random	NULL
hexanucleotides	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
Indianapolis	NULL
,	NULL
IN	NULL
)	NULL
and	NULL
avian	NULL
myeloblastosis	NULL
virus	NULL
(	NULL
AMV	NULL
)	NULL
reverse	NULL
transcriptase	NULL
(	NULL
Promega	NULL
,	NULL
Madi-son	NULL
,	NULL
WI	NULL
)	NULL
to	NULL
produce	NULL
cDNA	NULL
.	NULL

Dilutions	NULL
of	NULL
cDNAs	NULL
were	NULL
then	NULL
performed	NULL
to	NULL
allow	NULL
for	NULL
a	NULL
semiquantitative	NULL
estimate	NULL
of	NULL
the	NULL
original	NULL
murine	NULL
mRNA	NULL
steady	NULL
state	NULL
levels	NULL
using	NULL
the	NULL
PCR	NULL
and	NULL
species-specific	NULL
PCR	NULL
primers	NULL
.	NULL

Intron-spanning	NULL
murine-specific	NULL
primers	NULL
used	NULL
in	NULL
the	NULL
study	NULL
were	NULL
:	NULL
IL-2	NULL
:	NULL
upstream	NULL
,	NULL
-	NULL
5'-GTCACATTGACACTTGTGCTCC-3	NULL
'	NULL
;	NULL
downstream	NULL
,	NULL
5'-AGTCAAATCCAGAACATGCCG-3	NULL
'	NULL
(	NULL
GenBank	NULL
accession	NULL
no	NULL
.	NULL

M16760	NULL
and	NULL
M16761	NULL
)	NULL
;	NULL
lymphotactin	NULL
:	NULL
upstream	NULL
,	NULL
TCTCCTCCTGACTTITCC-3	NULL
'	NULL
;	NULL
-	NULL
downstream	NULL
,	NULL
-	NULL
5'-GGTGAATTCTTAC	NULL
CCAGTCAGGGTTATCGCTGTGC-3	NULL
'	NULL
(	NULL
GenBank	NULL
accession	NULL
nos	NULL
.	NULL

U28491	NULL
and	NULL
U28493	NULL
)	NULL
;	NULL
and	NULL
HPRT	NULL
(	NULL
hypoxanthine	NULL
phosphoribosyltransferase	NULL
)	NULL
:	NULL
upstream	NULL
,	NULL
-	NULL
5	NULL
``	NULL
-GTTGGATACAGGCCAGACTTTGTTG-3	NULL
'	NULL
;	NULL
downstream	NULL
,	NULL
5'-GAGGGTAGGCTGGCCTATAGGCT-3	NULL
'	NULL
(	NULL
GenBank	NULL
accession	NULL
no	NULL
.	NULL

JOO423	NULL
)	NULL
.	NULL

Intron-spanning	NULL
human-specific	NULL
primers	NULL
used	NULL
in	NULL
the	NULL
study	NULL
were	NULL
:	NULL
IL-2	NULL
:	NULL
upstream	NULL
,	NULL
downstream	NULL
,	NULL
5	NULL
'	NULL
A	NULL
fusion	NULL
:	NULL
unfused	NULL
fused	NULL
mAb	NULL
:	NULL
nil	NULL
mu	NULL
hu	NULL
mu	NULL
hu	NULL
%	NULL
«	NULL
mIl-2	NULL
Lymphotactin	NULL
hIL-2	NULL
®	NULL
»	NULL
MHPRT	NULL
sas	NULL
tll	NULL
--	NULL
was	NULL
wass	NULL
nis	NULL
Shite	NULL
Tt	NULL
aut	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
FIGURE	NULL
1	NULL
.	NULL

1461	NULL
CGTTGATATTGCTGATTAAGTCCCTG-3	NULL
'	NULL
(	NULL
GenBank	NULL
accession	NULL
no	NULL
.	NULL

X00695	NULL
)	NULL
;	NULL
and	NULL
HPRT	NULL
:	NULL
upstream	NULL
,	NULL
3	NULL
'	NULL
;	NULL
downstream	NULL
,	NULL
5'-GTCAATAGGACTCCAGATGTTC-3	NULL
'	NULL
(	NULL
GenBank	NULL
accession	NULL
no	NULL
.	NULL

M26434	NULL
)	NULL
.	NULL

To	NULL
enhance	NULL
primer	NULL
specificity	NULL
,	NULL
annealing	NULL
temperatures	NULL
for	NULL
the	NULL
initial	NULL
cycles	NULL
of	NULL
the	NULL
PCR	NULL
were	NULL
decreased	NULL
from	NULL
62	NULL
to	NULL
58°C	NULL
;	NULL
then	NULL
29	NULL
more	NULL
cycles	NULL
were	NULL
conducted	NULL
with	NULL
an	NULL
annealing	NULL
temperature	NULL
of	NULL
57°C	NULL
.	NULL

PCR	NULL
products	NULL
were	NULL
separated	NULL
by	NULL
1	NULL
%	NULL
agarose	NULL
gel	NULL
electrophoresis	NULL
and	NULL
visualized	NULL
either	NULL
by	NULL
ethidium	NULL
bromide	NULL
staining	NULL
within	NULL
the	NULL
gel	NULL
or	NULL
by	NULL
Southern	NULL
blotting	NULL
to	NULL
nylon	NULL
membrane	NULL
(	NULL
Magnagraph	NULL
Micron	NULL
Separation	NULL
,	NULL
Westborough	NULL
,	NULL
MA	NULL
)	NULL
with	NULL
detection	NULL
using	NULL
human	NULL
IL-2	NULL
,	NULL
murine	NULL
IL-2	NULL
,	NULL
and	NULL
murine	NULL
lymphotactin	NULL
gene	NULL
cDNA	NULL
probes	NULL
.	NULL

The	NULL
primers	NULL
amplified	NULL
DNAs	NULL
of	NULL
the	NULL
following	NULL
sizes	NULL
:	NULL
murine	NULL
IL-2	NULL
,	NULL
467	NULL
bp	NULL
;	NULL
murine	NULL
lymphotactin	NULL
,	NULL
444	NULL
bp	NULL
;	NULL
murine	NULL
HPRT	NULL
,	NULL
432	NULL
bp	NULL
;	NULL
human	NULL
IL-2	NULL
,	NULL
344	NULL
bp	NULL
;	NULL
and	NULL
human	NULL
HPRT	NULL
,	NULL
234	NULL
bp	NULL
.	NULL

Confocal	NULL
laser	NULL
microscopy	NULL
The	NULL
confocal	NULL
microscopy	NULL
analysis	NULL
used	NULL
PEG-treated	NULL
cultures	NULL
incubated	NULL
for	NULL
5	NULL
h	NULL
in	NULL
complete	NULL
medium	NULL
.	NULL

Viable	NULL
cells	NULL
were	NULL
then	NULL
attached	NULL
to	NULL
coverslips	NULL
precoated	NULL
with	NULL
1	NULL
mg/ml	NULL
Con	NULL
A	NULL
(	NULL
Pharmacia	NULL
)	NULL
by	NULL
centrifugation	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
with	NULL
anti-human	NULL
CD45-biotin	NULL
(	NULL
PharMingen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
for	NULL
20	NULL
min	NULL
,	NULL
washed	NULL
in	NULL
sorter	NULL
buffer	NULL
,	NULL
and	NULL
then	NULL
incubated	NULL
for	NULL
20	NULL
min	NULL
more	NULL
with	NULL
anti-murine	NULL
CD4-FITC	NULL
(	NULL
Caltag	NULL
,	NULL
South	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
streptavi-din-Cy5	NULL
(	NULL
Jackson	NULL
ImmunoResearch	NULL
Laboratories	NULL
,	NULL
West	NULL
Grove	NULL
,	NULL
PA	NULL
)	NULL
.	NULL

Washed	NULL
cells	NULL
were	NULL
fixed	NULL
with	NULL
2	NULL
%	NULL
paraformaldehyde	NULL
for	NULL
20	NULL
min	NULL
and	NULL
then	NULL
permeabilized	NULL
with	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
(	NULL
Sigma	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
for	NULL
2	NULL
min	NULL
.	NULL

Washed	NULL
cells	NULL
were	NULL
exposed	NULL
to	NULL
1	NULL
mg/ml	NULL
RNase	NULL
A	NULL
for	NULL
10	NULL
min	NULL
at	NULL
37°C	NULL
followed	NULL
by	NULL
air-drying	NULL
.	NULL

In	NULL
the	NULL
final	NULL
incubation	NULL
step	NULL
,	NULL
ethidium	NULL
bromide	NULL
was	NULL
added	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
1	NULL
pg/ml	NULL
for	NULL
5	NULL
min	NULL
followed	NULL
by	NULL
washing	NULL
of	NULL
the	NULL
cells	NULL
.	NULL

Coverslips	NULL
were	NULL
mounted	NULL
to	NULL
slides	NULL
,	NULL
and	NULL
images	NULL
were	NULL
collected	NULL
on	NULL
a	NULL
Bio-Rad	NULL
MRC	NULL
1000	NULL
confocal	NULL
laser	NULL
microscope	NULL
using	NULL
COMOS	NULL
version	NULL
6.05.8	NULL
software	NULL
(	NULL
Bio-Rad	NULL
Microscience	NULL
,	NULL
Herts	NULL
,	NULL
U.K.	NULL
)	NULL
.	NULL

Grey	NULL
scale	NULL
images	NULL
were	NULL
electronically	NULL
collected	NULL
using	NULL
488	NULL
nm	NULL
(	NULL
murine	NULL
CD4	NULL
)	NULL
,	NULL
568	NULL
nm	NULL
(	NULL
ethidium	NULL
bromide	NULL
)	NULL
,	NULL
and	NULL
647	NULL
nm	NULL
(	NULL
human	NULL
CD45	NULL
)	NULL
fluorescence	NULL
laser	NULL
exci-tation	NULL
;	NULL
a	NULL
X60	NULL
objective	NULL
;	NULL
and	NULL
a	NULL
Kalman	NULL
filter	NULL
(	NULL
16	NULL
scans	NULL
)	NULL
.	NULL

Images	NULL
were	NULL
then	NULL
imported	NULL
into	NULL
Adobe	NULL
Photoshop	NULL
software	NULL
(	NULL
Adobe	NULL
Systems	NULL
,	NULL
San	NULL
Jose	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
pseudo-colored	NULL
(	NULL
murine	NULL
CD4	NULL
fluorescence	NULL
emission	NULL
as	NULL
green	NULL
,	NULL
human	NULL
CD45	NULL
as	NULL
red	NULL
,	NULL
and	NULL
ethidium	NULL
as	NULL
blue	NULL
)	NULL
,	NULL
and	NULL
merged	NULL
.	NULL

Flow	NULL
cytometry	NULL
For	NULL
the	NULL
murine/human	NULL
heterokaryons	NULL
,	NULL
PEG-treated	NULL
cultures	NULL
were	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
30	NULL
min	NULL
with	NULL
a	NULL
mixture	NULL
of	NULL
anti-human	NULL
CD45-CyChrome	NULL
(	NULL
PharMingen	NULL
)	NULL
and	NULL
anti-murine	NULL
CD4-PE	NULL
(	NULL
PharMingen	NULL
)	NULL
in	NULL
sorter	NULL
buffer	NULL
containing	NULL
RT-PCR	NULL
analysis	NULL
of	NULL
murine	NULL
IL-2	NULL
,	NULL
lymphotactin	NULL
,	NULL
and	NULL
HPRT	NULL
gene	NULL
expression	NULL
as	NULL
well	NULL
as	NULL
human	NULL
IL-2	NULL
in	NULL
unfused	NULL
or	NULL
fused	NULL
mixtures	NULL
of	NULL
murine	NULL
and	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
16B.2	NULL
murine	NULL
T	NULL
cells	NULL
and	NULL
Jurkat	NULL
human	NULL
T	NULL
cells	NULL
were	NULL
mixed	NULL
either	NULL
without	NULL
(	NULL
unfused	NULL
)	NULL
or	NULL
with	NULL
(	NULL
fused	NULL
)	NULL
exposure	NULL
to	NULL
PEG	NULL
,	NULL
were	NULL
recovered	NULL
and	NULL
washed	NULL
,	NULL
and	NULL
then	NULL
were	NULL
incubated	NULL
for	NULL
6	NULL
h	NULL
with	NULL
no	NULL
stimulus	NULL
(	NULL
nil	NULL
)	NULL
,	NULL
anti-murine	NULL
CD3	NULL
plus	NULL
CD28	NULL
mAbs	NULL
(	NULL
mu	NULL
)	NULL
,	NULL
or	NULL
anti-human	NULL
CD3	NULL
plus	NULL
CD28	NULL
mAbs	NULL
(	NULL
hu	NULL
)	NULL
.	NULL

Cellular	NULL
RNA	NULL
was	NULL
isolated	NULL
and	NULL
reverse	NULL
transcribed	NULL
,	NULL
then	NULL
PCR	NULL
was	NULL
performed	NULL
on	NULL
aliquots	NULL
using	NULL
the	NULL
indicated	NULL
(	NULL
murine	NULL
IL-2	NULL
,	NULL
lymphotactin	NULL
,	NULL
human	NULL
IL-2	NULL
,	NULL
or	NULL
murine	NULL
HPRT	NULL
)	NULL
primer	NULL
pairs	NULL
.	NULL

Lane	NULL
6	NULL
represents	NULL
PCR	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
a	NULL
cDNA	NULL
template	NULL
.	NULL

Murine	NULL
HPRT	NULL
gene	NULL
expression	NULL
was	NULL
analyzed	NULL
to	NULL
control	NULL
for	NULL
mRNA	NULL
integrity	NULL
and	NULL
loading	NULL
.	NULL

PCR	NULL
products	NULL
using	NULL
the	NULL
IL-2	NULL
primers	NULL
were	NULL
detected	NULL
by	NULL
Southern	NULL
blotting	NULL
,	NULL
whereas	NULL
lymphotactin	NULL
and	NULL
mHPRT	NULL
results	NULL
were	NULL
determined	NULL
by	NULL
ethidium	NULL
bromide	NULL
staining	NULL
of	NULL
the	NULL
gel	NULL
.	NULL

This	NULL
experiment	NULL
is	NULL
representative	NULL
of	NULL
five	NULL
additional	NULL
experiments	NULL
.	NULL

B	NULL
,	NULL
Immunofluorescence	NULL
staining	NULL
and	NULL
confocal	NULL
microscopic	NULL
analysis	NULL
of	NULL
PEG-fused	NULL
murine	NULL
16B.2	NULL
and	NULL
human	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

Green	NULL
color	NULL
represents	NULL
murine	NULL
CD4	NULL
staining	NULL
;	NULL
red	NULL
color	NULL
represents	NULL
human	NULL
CD45	NULL
staining	NULL
;	NULL
blue	NULL
color	NULL
represents	NULL
ethidium	NULL
bromide	NULL
staining	NULL
of	NULL
cell	NULL
nuclei	NULL
.	NULL

Yellow	NULL
color	NULL
indicates	NULL
areas	NULL
of	NULL
contiguous	NULL
murine	NULL
CD4	NULL
and	NULL
human	NULL
CD45	NULL
staining	NULL
.	NULL

Two	NULL
separate	NULL
fields	NULL
from	NULL
the	NULL
same	NULL
experiment	NULL
are	NULL
shown	NULL
.	NULL

A	NULL
second	NULL
experiment	NULL
was	NULL
performed	NULL
with	NULL
essentially	NULL
identical	NULL
results	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
1462	NULL
1	NULL
%	NULL
FCS	NULL
and	NULL
0.05	NULL
%	NULL
sodium	NULL
azide	NULL
in	NULL
PBS	NULL
.	NULL

Cell	NULL
fusion	NULL
was	NULL
then	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
using	NULL
a	NULL
FACScan	NULL
cytometer	NULL
and	NULL
CellQuest	NULL
software	NULL
(	NULL
Bec-ton	NULL
Dickinson	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
murine/murine	NULL
heterokaryons	NULL
,	NULL
A.E7	NULL
or	NULL
16B.2	NULL
T	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
the	NULL
fluorescence	NULL
tracking	NULL
dye	NULL
carboxyfluorescein	NULL
diacetate/succinimidyl	NULL
ester	NULL
(	NULL
CFSE	NULL
;	NULL
Molecular	NULL
Probes	NULL
,	NULL
Eugene	NULL
,	NULL
OR	NULL
)	NULL
at	NULL
a	NULL
0.5-nM	NULL
concentration	NULL
before	NULL
fusion	NULL
.	NULL

PEG-treated	NULL
cultures	NULL
were	NULL
then	NULL
stimulated	NULL
in	NULL
plates	NULL
for	NULL
2	NULL
h	NULL
with	NULL
either	NULL
the	NULL
combination	NULL
of	NULL
CD3	NULL
plus	NULL
CD28	NULL
mAbs	NULL
or	NULL
with	NULL
Iono	NULL
plus	NULL
PMA	NULL
.	NULL

At	NULL
that	NULL
time	NULL
,	NULL
10	NULL
pg/ml	NULL
brefeldin	NULL
A	NULL
(	NULL
Sigma	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
cultures	NULL
,	NULL
and	NULL
incubation	NULL
was	NULL
continued	NULL
for	NULL
an	NULL
additional	NULL
5	NULL
h.	NULL
Cultures	NULL
were	NULL
harvested	NULL
and	NULL
stained	NULL
with	NULL
KJ1-26-biotin/streptavidin-CyChrome	NULL
(	NULL
PharMingen	NULL
)	NULL
followed	NULL
by	NULL
fixation	NULL
with	NULL
4	NULL
%	NULL
formaldehyde	NULL
and	NULL
detection	NULL
of	NULL
intracellular	NULL
IL-2	NULL
with	NULL
anti-IL-2-PE	NULL
(	NULL
PharMingen	NULL
)	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
16	NULL
)	NULL
.	NULL

CFSE*	NULL
KJ1-26*	NULL
heterokaryons	NULL
were	NULL
electronically	NULL
gated	NULL
,	NULL
and	NULL
IL-2	NULL
accumulation	NULL
was	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
normal	NULL
KJ1-26*	NULL
T	NULL
cells	NULL
.	NULL

Results	NULL
and	NULL
Discussion	NULL
Functional	NULL
murine/human	NULL
heterokaryons	NULL
can	NULL
be	NULL
detected	NULL
following	NULL
fusion	NULL
of	NULL
normal	NULL
murine	NULL
cloned	NULL
T	NULL
cells	NULL
and	NULL
Jurkat	NULL
human	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PEG	NULL
The	NULL
mRNA	NULL
harvested	NULL
from	NULL
unfused	NULL
mixtures	NULL
of	NULL
murine	NULL
cloned	NULL
CD4	NULL
*	NULL
Th	NULL
cells	NULL
and	NULL
human	NULL
Jurkat	NULL
cells	NULL
contained	NULL
detectable	NULL
transcripts	NULL
for	NULL
murine	NULL
IL-2	NULL
only	NULL
when	NULL
the	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
an	NULL
mAb	NULL
pair	NULL
specific	NULL
for	NULL
murine	NULL
CD3	NULL
and	NULL
CD28	NULL
molecules	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Anti-CD3	NULL
and	NULL
-CD28	NULL
mAbs	NULL
reactive	NULL
with	NULL
human	NULL
mole-cules	NULL
,	NULL
while	NULL
capable	NULL
of	NULL
inducing	NULL
the	NULL
production	NULL
of	NULL
human	NULL
IL-2	NULL
mRNA	NULL
by	NULL
the	NULL
Jurkat	NULL
cells	NULL
within	NULL
the	NULL
mixed	NULL
population	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
did	NULL
not	NULL
stimulate	NULL
murine	NULL
IL-2	NULL
mRNA	NULL
detectable	NULL
by	NULL
RT-PCR	NULL
,	NULL
confirming	NULL
the	NULL
species	NULL
specificity	NULL
of	NULL
both	NULL
the	NULL
anti-human	NULL
Abs	NULL
and	NULL
the	NULL
PCR	NULL
primers	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
exposure	NULL
of	NULL
mixed	NULL
cell	NULL
populations	NULL
(	NULL
murine	NULL
Th	NULL
cells	NULL
plus	NULL
Jurkat	NULL
)	NULL
to	NULL
PEG	NULL
resulted	NULL
in	NULL
the	NULL
appearance	NULL
of	NULL
mRNA	NULL
for	NULL
murine	NULL
IL-2	NULL
that	NULL
could	NULL
be	NULL
easily	NULL
detected	NULL
after	NULL
stimulation	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
Abs	NULL
against	NULL
human	NULL
CD3	NULL
and	NULL
CD28	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

This	NULL
result	NULL
showed	NULL
that	NULL
functional	NULL
murine/	NULL
human	NULL
heterokaryons	NULL
do	NULL
form	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PEG	NULL
.	NULL

In	NULL
each	NULL
of	NULL
seven	NULL
experiments	NULL
using	NULL
a	NULL
semiquantitative	NULL
RT-PCR	NULL
detection	NULL
method	NULL
,	NULL
murine	NULL
IL-2	NULL
mRNA	NULL
was	NULL
produced	NULL
in	NULL
response	NULL
to	NULL
anti-human	NULL
mAbs	NULL
only	NULL
after	NULL
exposure	NULL
to	NULL
PEG	NULL
,	NULL
and	NULL
the	NULL
amount	NULL
of	NULL
mRNA	NULL
observed	NULL
was	NULL
9	NULL
+	NULL
4	NULL
%	NULL
that	NULL
seen	NULL
following	NULL
anti-mouse	NULL
CD3	NULL
plus	NULL
CD28	NULL
stimulation	NULL
.	NULL

This	NULL
production	NULL
of	NULL
murine	NULL
IL-2	NULL
mRNA	NULL
in	NULL
response	NULL
to	NULL
anti-human	NULL
reagents	NULL
,	NULL
while	NULL
relatively	NULL
small	NULL
,	NULL
was	NULL
consistent	NULL
with	NULL
the	NULL
modest	NULL
frequency	NULL
(	NULL
2.6	NULL
+	NULL
0.4	NULL
%	NULL
;	NULL
n	NULL
=	NULL
9	NULL
)	NULL
of	NULL
heterokaryon	NULL
formation	NULL
that	NULL
was	NULL
observed	NULL
using	NULL
FACS	NULL
to	NULL
identify	NULL
cells	NULL
that	NULL
simultaneously	NULL
expressed	NULL
both	NULL
murine	NULL
and	NULL
human	NULL
surface	NULL
markers	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Double-labeled	NULL
murine/human	NULL
heterokaryons	NULL
were	NULL
similarly	NULL
detected	NULL
in	NULL
PEG-fused	NULL
populations	NULL
using	NULL
confocal	NULL
microscopy	NULL
,	NULL
and	NULL
they	NULL
consistently	NULL
(	NULL
in	NULL
each	NULL
of	NULL
22	NULL
murine/human	NULL
heterokaryons	NULL
analyzed	NULL
)	NULL
demonstrated	NULL
the	NULL
presence	NULL
of	NULL
at	NULL
least	NULL
one	NULL
denser	NULL
murine	NULL
T	NULL
cell	NULL
nucleus	NULL
plus	NULL
one	NULL
larger	NULL
human	NULL
Jurkat-derived	NULL
nucleus	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
a	NULL
B-galactosidase	NULL
reporter	NULL
gene	NULL
(	NULL
regulated	NULL
by	NULL
a	NULL
multimer	NULL
of	NULL
the	NULL
DNA	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
)	NULL
stably	NULL
transfected	NULL
into	NULL
Jurkat	NULL
could	NULL
be	NULL
detected	NULL
by	NULL
three-color	NULL
flow	NULL
cytometry	NULL
following	NULL
stimulation	NULL
with	NULL
anti-murine	NULL
CD3	NULL
and	NULL
CD28	NULL
only	NULL
after	NULL
fusion	NULL
with	NULL
the	NULL
mouse	NULL
cloned	NULL
T	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Using	NULL
RT-PCR	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
a	NULL
second	NULL
murine	NULL
gene	NULL
called	NULL
lymphotactin	NULL
(	NULL
8	NULL
,	NULL
17	NULL
)	NULL
was	NULL
also	NULL
examined	NULL
in	NULL
these	NULL
heterokaryons	NULL
,	NULL
and	NULL
its	NULL
transcription	NULL
was	NULL
similarly	NULL
induced	NULL
by	NULL
anti-human	NULL
CD3	NULL
and	NULL
CD28	NULL
mAbs	NULL
only	NULL
in	NULL
PEG-fused	NULL
populations	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
sufficient	NULL
similarities	NULL
must	NULL
exist	NULL
between	NULL
the	NULL
signaling	NULL
cascades	NULL
of	NULL
man	NULL
and	NULL
mouse	NULL
such	NULL
that	NULL
stimulation	NULL
of	NULL
human	NULL
CD3	NULL
and	NULL
CD28	NULL
molecules	NULL
can	NULL
fully	NULL
activate	NULL
murine	NULL
gene	NULL
transcription	NULL
in	NULL
the	NULL
murine/human	NULL
heterokaryons	NULL
.	NULL

We	NULL
then	NULL
took	NULL
advantage	NULL
of	NULL
these	NULL
similarities	NULL
to	NULL
test	NULL
whether	NULL
signaling	NULL
molecules	NULL
provided	NULL
by	NULL
human	NULL
Jurkat	NULL
cells	NULL
could	NULL
restore	NULL
normal	NULL
signal	NULL
transduction	NULL
to	NULL
the	NULL
murine	NULL
IL-2	NULL
gene	NULL
after	NULL
fusion	NULL
with	NULL
an	NULL
anergic	NULL
murine	NULL
Th	NULL
cell	NULL
.	NULL

MOLECULAR	NULL
REPRESSOR	NULL
IN	NULL
ANERGIC	NULL
T	NULL
HETEROKARYONS	NULL
A	NULL
CD3/CD28	NULL
mAbs	NULL
nil	NULL
anti-murine	NULL
anti-human	NULL
Group	NULL
>	NULL
N	NULL
-	NULL
A	NULL
-	NULL
No-	NULL
P-	NULL
Rts	NULL
im	NULL
``	NULL
an	NULL
``	NULL
®t	NULL
C	NULL
C	NULL
i	NULL
&	NULL
akc	NULL
i	NULL
ok	NULL
&	NULL
o	NULL
Pb	NULL
c	NULL
d	NULL
4	NULL
few.-	NULL
«	NULL
_-	NULL
-.-	NULL
«	NULL
nook-0-	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
4	NULL
mIL-2	NULL
Lymphotactin	NULL
Anergic	NULL
int	NULL
D	NULL
murine	NULL
CD4	NULL
PE	NULL
19	NULL
WI	NULL
murine	NULL
CD4	NULL
PE	NULL
if	NULL
(	NULL
e	NULL
fu	NULL
``	NULL
w	NULL
10	NULL
!	NULL

human	NULL
A	NULL
mvp	NULL
,	NULL
``	NULL
who	NULL
onl	NULL
ist	NULL
wt	NULL
who	NULL
a	NULL
CD45	NULL
Cy-Chrome	NULL
human	NULL
CD45	NULL
Cy-ghronjm	NULL
FIGURE	NULL
2	NULL
.	NULL

-	NULL
Fusion	NULL
of	NULL
Jurkat	NULL
T	NULL
cells	NULL
with	NULL
anergic	NULL
CD4*	NULL
Th	NULL
cells	NULL
fails	NULL
to	NULL
restore	NULL
murine	NULL
IL-2	NULL
gene	NULL
inducibility	NULL
.	NULL

Normal	NULL
(	NULL
N	NULL
)	NULL
or	NULL
anergic	NULL
(	NULL
A	NULL
)	NULL
A.E7	NULL
murine	NULL
Th	NULL
cells	NULL
were	NULL
mixed	NULL
with	NULL
Jurkat	NULL
human	NULL
T	NULL
cells	NULL
and	NULL
exposed	NULL
to	NULL
PEG	NULL
to	NULL
allow	NULL
the	NULL
formation	NULL
of	NULL
heterokaryons	NULL
.	NULL

A	NULL
,	NULL
Cell	NULL
mixtures	NULL
were	NULL
analyzed	NULL
for	NULL
expression	NULL
of	NULL
the	NULL
indicated	NULL
(	NULL
murine	NULL
IL-2	NULL
and	NULL
lymphofactin	NULL
)	NULL
murine	NULL
mRNA	NULL
by	NULL
RT-PCR	NULL
following	NULL
6	NULL
h	NULL
of	NULL
incubation	NULL
either	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Abs	NULL
(	NULL
nil	NULL
)	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
anti-murine	NULL
or	NULL
anti-human	NULL
CD3	NULL
plus	NULL
CD28	NULL
mAbs	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

The	NULL
cDNA	NULL
templates	NULL
were	NULL
diluted	NULL
as	NULL
indicated	NULL
before	NULL
PCR	NULL
and	NULL
detection	NULL
by	NULL
Southern	NULL
blotting	NULL
.	NULL

Murine	NULL
HPRT	NULL
expression	NULL
was	NULL
also	NULL
determined	NULL
for	NULL
each	NULL
sample	NULL
,	NULL
and	NULL
this	NULL
showed	NULL
equivalent	NULL
mRNA	NULL
recovery	NULL
and	NULL
integrity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

B	NULL
,	NULL
Surface	NULL
expression	NULL
of	NULL
human	NULL
CD45	NULL
and	NULL
mouse	NULL
CD4	NULL
molecules	NULL
determined	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

Each	NULL
experiment	NULL
shown	NULL
(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
is	NULL
representative	NULL
of	NULL
at	NULL
least	NULL
two	NULL
additional	NULL
experiments	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

Fusion	NULL
of	NULL
anergic	NULL
murine	NULL
T	NULL
cells	NULL
with	NULL
Jurkat	NULL
fails	NULL
to	NULL
overcome	NULL
the	NULL
anergy	NULL
defect	NULL
Clonal	NULL
anergy	NULL
was	NULL
induced	NULL
in	NULL
cloned	NULL
murine	NULL
T	NULL
cells	NULL
by	NULL
overnight	NULL
exposure	NULL
to	NULL
immobilized	NULL
CD3	NULL
mAb	NULL
to	NULL
mimic	NULL
Ag	NULL
recognition	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
CD28	NULL
costimulation	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
8	NULL
)	NULL
.	NULL

The	NULL
T	NULL
cells	NULL
were	NULL
then	NULL
allowed	NULL
to	NULL
incubate	NULL
in	NULL
medium	NULL
alone	NULL
for	NULL
6	NULL
days	NULL
,	NULL
in	NULL
parallel	NULL
with	NULL
a	NULL
normal	NULL
control	NULL
T	NULL
cell	NULL
population	NULL
that	NULL
had	NULL
not	NULL
been	NULL
exposed	NULL
to	NULL
the	NULL
CD3	NULL
mAb	NULL
.	NULL

Upon	NULL
rechallenge	NULL
with	NULL
Ag	NULL
,	NULL
the	NULL
CD3-pretreated	NULL
T	NULL
cells	NULL
showed	NULL
a	NULL
substantially	NULL
reduced	NULL
IL-2	NULL
production	NULL
and	NULL
proliferation	NULL
compared	NULL
with	NULL
the	NULL
control	NULL
population	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
clonal	NULL
anergy	NULL
.	NULL

Each	NULL
group	NULL
of	NULL
murine	NULL
cloned	NULL
T	NULL
cells	NULL
was	NULL
then	NULL
mixed	NULL
with	NULL
Jurkat	NULL
,	NULL
fused	NULL
in	NULL
PEG	NULL
,	NULL
and	NULL
subsequently	NULL
examined	NULL
for	NULL
mRNA	NULL
synthesis	NULL
following	NULL
stimulation	NULL
with	NULL
the	NULL
CD3	NULL
and	NULL
CD28	NULL
mAb	NULL
pairs	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

Anergic	NULL
T	NULL
cells	NULL
expressed	NULL
significantly	NULL
fewer	NULL
murine	NULL
IL-2	NULL
mRNA	NULL
transcripts	NULL
than	NULL
control	NULL
cells	NULL
upon	NULL
stimulation	NULL
with	NULL
the	NULL
anti-murine	NULL
CD3	NULL
and	NULL
CD28	NULL
mAbs	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
compare	NULL
lanes	NULL
3-7	NULL
to	NULL
lanes	NULL
8-11	NULL
)	NULL
.	NULL

This	NULL
was	NULL
the	NULL
expected	NULL
result	NULL
,	NULL
since	NULL
heterokaryon	NULL
formation	NULL
occurred	NULL
only	NULL
at	NULL
low	NULL
frequency	NULL
,	NULL
and	NULL
no	NULL
effect	NULL
of	NULL
the	NULL
Jurkat	NULL
cells	NULL
was	NULL
anticipated	NULL
on	NULL
the	NULL
majority	NULL
of	NULL
the	NULL
nonfused	NULL
murine	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
culture	NULL
.	NULL

Murine	NULL
Iymphotactin	NULL
mRNA	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
was	NULL
strongly	NULL
induced	NULL
in	NULL
the	NULL
anergic	NULL
group	NULL
by	NULL
the	NULL
anti-murine	NULL
mAb	NULL
stimulation	NULL
as	NULL
previously	NULL
reported	NULL
(	NULL
8	NULL
)	NULL
,	NULL
again	NULL
indicating	NULL
that	NULL
some	NULL
signaling	NULL
pathways	NULL
between	NULL
the	NULL
plasma	NULL
membrane	NULL
and	NULL
the	NULL
nucleus	NULL
remained	NULL
intact	NULL
within	NULL
the	NULL
anergic	NULL
murine	NULL
Th	NULL
cells	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
-	NULL
CD3/CD28	NULL
mAbs	NULL
nil	NULL
anti-murine	NULL
anti-human	NULL
itm	NULL
.	NULL

Rite	NULL
Group	NULL
Normal	NULL
«	NULL
--	NULL
-	NULL
«	NULL
»	NULL
»	NULL
-~	NULL
WA*	NULL
1:5	NULL
-	NULL
(	NULL
h	NULL
)	NULL
1:5	NULL
1:25	NULL
1:125	NULL
(	NULL
h	NULL
)	NULL
1:5	NULL
1:25	NULL
1:125	NULL
(	NULL
h	NULL
)	NULL
|__	NULL
``	NULL
``	NULL
e	NULL
|___	NULL
ee	NULL
Anergic	NULL
woes	NULL
..	NULL
With	NULL
oo	NULL
___	NULL
nd	NULL
1:5	NULL
(	NULL
h	NULL
)	NULL
1:15	NULL
1:25	NULL
1:125	NULL
.	NULL

(	NULL
h	NULL
)	NULL
1:5	NULL
1:25	NULL
1:125	NULL
(	NULL
h	NULL
)	NULL
cDNA	NULL
dilution	NULL
for	NULL
hIL-2	NULL
hHPRT	NULL
lane	NULL
(	NULL
h	NULL
)	NULL
FIGURE	NULL
3	NULL
.	NULL

Repression	NULL
of	NULL
human	NULL
IL-2	NULL
mRNA	NULL
expression	NULL
following	NULL
fusion	NULL
of	NULL
Jurkat	NULL
human	NULL
T	NULL
cells	NULL
with	NULL
anergic	NULL
murine	NULL
cells	NULL
.	NULL

Normal	NULL
or	NULL
anergic	NULL
A.E7	NULL
murine	NULL
T	NULL
cells	NULL
were	NULL
mixed	NULL
with	NULL
Jurkat	NULL
cells	NULL
and	NULL
exposed	NULL
to	NULL
PEG	NULL
.	NULL

Fused	NULL
cultures	NULL
were	NULL
then	NULL
incubated	NULL
for	NULL
6	NULL
h	NULL
either	NULL
without	NULL
stimulation	NULL
or	NULL
with	NULL
one	NULL
of	NULL
the	NULL
anti-murine	NULL
or	NULL
anti-human	NULL
CD3	NULL
plus	NULL
CD28	NULL
mAb	NULL
pairs	NULL
,	NULL
followed	NULL
by	NULL
extraction	NULL
of	NULL
mRNA	NULL
and	NULL
RT	NULL
.	NULL

cDNA	NULL
templates	NULL
were	NULL
diluted	NULL
as	NULL
shown	NULL
and	NULL
then	NULL
amplified	NULL
with	NULL
human	NULL
IL-2-specific	NULL
primers	NULL
with	NULL
PCR	NULL
products	NULL
detected	NULL
by	NULL
Southern	NULL
blotting	NULL
or	NULL
were	NULL
amplified	NULL
with	NULL
hHPRT	NULL
primers	NULL
and	NULL
detected	NULL
by	NULL
ethidium	NULL
bromide	NULL
staining	NULL
as	NULL
indicated	NULL
(	NULL
R	NULL
)	NULL
.	NULL

Upon	NULL
stimulation	NULL
of	NULL
the	NULL
PEG-fused	NULL
anergic	NULL
group	NULL
with	NULL
anti-human	NULL
CD3	NULL
and	NULL
CD28	NULL
mAbs	NULL
to	NULL
focus	NULL
attention	NULL
solely	NULL
on	NULL
the	NULL
murine/human	NULL
heterokaryons	NULL
in	NULL
the	NULL
culture	NULL
,	NULL
the	NULL
defect	NULL
in	NULL
murine	NULL
IL-2	NULL
mRNA	NULL
induction	NULL
persisted	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
,	NULL
compare	NULL
lanes	NULL
12	NULL
and	NULL
13	NULL
with	NULL
lanes	NULL
14	NULL
and	NULL
15	NULL
)	NULL
.	NULL

A	NULL
correction	NULL
of	NULL
the	NULL
clonal	NULL
anergy	NULL
IL-2	NULL
mRNA	NULL
synthesis	NULL
defect	NULL
was	NULL
never	NULL
observed	NULL
in	NULL
five	NULL
separate	NULL
fusion	NULL
experiments	NULL
,	NULL
and	NULL
murine	NULL
IL-2	NULL
mRNA	NULL
inducibility	NULL
within	NULL
these	NULL
anergic	NULL
heterokaryons	NULL
remained	NULL
reduced	NULL
by	NULL
an	NULL
average	NULL
of	NULL
80	NULL
+	NULL
5	NULL
%	NULL
.	NULL

This	NULL
failure	NULL
of	NULL
the	NULL
anergic	NULL
group	NULL
to	NULL
synthesize	NULL
murine	NULL
IL-2	NULL
mRNA	NULL
in	NULL
response	NULL
to	NULL
the	NULL
anti-human	NULL
mAb	NULL
pair	NULL
was	NULL
not	NULL
simply	NULL
the	NULL
result	NULL
of	NULL
a	NULL
decreased	NULL
capacity	NULL
of	NULL
anergic	NULL
murine	NULL
cells	NULL
to	NULL
form	NULL
a	NULL
viable	NULL
heterokaryon	NULL
with	NULL
Jurkat	NULL
,	NULL
since	NULL
murine	NULL
lymphotactin	NULL
mRNA	NULL
could	NULL
still	NULL
be	NULL
normally	NULL
induced	NULL
with	NULL
the	NULL
combination	NULL
of	NULL
anti-human	NULL
mAbs	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
anergic	NULL
T	NULL
cells	NULL
were	NULL
observed	NULL
to	NULL
1463	NULL
form	NULL
heterokaryons	NULL
with	NULL
Jurkat	NULL
with	NULL
a	NULL
frequency	NULL
similar	NULL
to	NULL
that	NULL
in	NULL
normal	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
a	NULL
defect	NULL
in	NULL
signal	NULL
transduction	NULL
to	NULL
the	NULL
murine	NULL
IL-2	NULL
gene	NULL
that	NULL
exists	NULL
in	NULL
anergic	NULL
T	NULL
cells	NULL
could	NULL
not	NULL
be	NULL
overcome	NULL
by	NULL
fusion	NULL
and	NULL
mixing	NULL
of	NULL
anergic	NULL
cell	NULL
contents	NULL
with	NULL
Jurkat	NULL
.	NULL

A	NULL
dominant-acting	NULL
repressor	NULL
molecule	NULL
in	NULL
viable	NULL
anergic	NULL
T	NULL
cells	NULL
Human	NULL
IL-2	NULL
gene	NULL
inducibility	NULL
was	NULL
also	NULL
examined	NULL
following	NULL
fusion	NULL
of	NULL
Jurkat	NULL
to	NULL
the	NULL
anergic	NULL
mouse	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Anergic	NULL
murine/	NULL
human	NULL
heterokaryons	NULL
demonstrated	NULL
defective	NULL
human	NULL
IL-2	NULL
gene	NULL
transcription	NULL
following	NULL
CD3	NULL
and	NULL
CD28	NULL
stimulation	NULL
with	NULL
the	NULL
anti-mouse	NULL
mAb	NULL
pair	NULL
compared	NULL
with	NULL
normal	NULL
heterokaryons	NULL
.	NULL

In	NULL
five	NULL
separate	NULL
experiments	NULL
,	NULL
human	NULL
IL-2	NULL
gene	NULL
inducibility	NULL
was	NULL
reduced	NULL
78	NULL
+	NULL
9	NULL
%	NULL
following	NULL
fusion	NULL
with	NULL
anergic	NULL
T	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
a	NULL
molecule	NULL
within	NULL
the	NULL
anergic	NULL
murine	NULL
T	NULL
cell	NULL
was	NULL
capable	NULL
of	NULL
interrupting	NULL
the	NULL
normal	NULL
cascade	NULL
of	NULL
signals	NULL
from	NULL
the	NULL
plasma	NULL
membrane	NULL
to	NULL
the	NULL
human	NULL
IL-2	NULL
gene	NULL
when	NULL
introduced	NULL
into	NULL
Jurkat	NULL
T	NULL
cells	NULL
.	NULL

These	NULL
findings	NULL
rule	NULL
out	NULL
the	NULL
simple	NULL
hypothesis	NULL
that	NULL
an	NULL
inactivation	NULL
or	NULL
degradation	NULL
of	NULL
one	NULL
proximal	NULL
signal	NULL
transduction	NULL
component	NULL
accounts	NULL
for	NULL
the	NULL
inability	NULL
of	NULL
anergic	NULL
T	NULL
cells	NULL
to	NULL
activate	NULL
the	NULL
IL-2	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

Even	NULL
if	NULL
the	NULL
human	NULL
counterpart	NULL
of	NULL
such	NULL
a	NULL
putative	NULL
defective	NULL
component	NULL
failed	NULL
to	NULL
act	NULL
in	NULL
its	NULL
place	NULL
because	NULL
of	NULL
a	NULL
species	NULL
difference	NULL
(	NULL
which	NULL
is	NULL
unlikely	NULL
given	NULL
the	NULL
conservation	NULL
between	NULL
man	NULL
and	NULL
mouse	NULL
of	NULL
the	NULL
signaling	NULL
cascades	NULL
)	NULL
,	NULL
one	NULL
should	NULL
have	NULL
expected	NULL
multiple	NULL
cross-species	NULL
interactions	NULL
within	NULL
the	NULL
signaling	NULL
cascade	NULL
of	NULL
the	NULL
heterokaryon	NULL
distal	NULL
to	NULL
the	NULL
murine	NULL
signaling	NULL
block	NULL
.	NULL

Instead	NULL
,	NULL
the	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
induction	NULL
of	NULL
clonal	NULL
anergy	NULL
in	NULL
CD4	NULL
*	NULL
Th	NULL
cells	NULL
results	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
dominant-acting	NULL
repressor	NULL
molecule	NULL
capable	NULL
of	NULL
inhibiting	NULL
a	NULL
signal	NULL
transduction	NULL
cascade	NULL
involving	NULL
normal	NULL
components	NULL
from	NULL
both	NULL
species	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

We	NULL
independently	NULL
tested	NULL
this	NULL
final	NULL
hypothesis	NULL
using	NULL
a	NULL
flow	NULL
cy-tometric	NULL
approach	NULL
to	NULL
examine	NULL
the	NULL
inducibility	NULL
of	NULL
intracellular	NULL
IL-2	NULL
protein	NULL
accumulation	NULL
after	NULL
the	NULL
fusion	NULL
of	NULL
one	NULL
anergic	NULL
murine	NULL
T	NULL
cell	NULL
to	NULL
another	NULL
normal	NULL
murine	NULL
cell	NULL
.	NULL

KJ1-26	NULL
*	NULL
T	NULL
cells	NULL
cultivated	NULL
in	NULL
vitro	NULL
by	NULL
intermittent	NULL
Ag	NULL
stimulation	NULL
are	NULL
normally	NULL
heavy	NULL
IL-2	NULL
producers	NULL
and	NULL
demonstrate	NULL
significant	NULL
intracellular	NULL
IL-2	NULL
accumulation	NULL
in	NULL
response	NULL
to	NULL
activation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
brefeldin	NULL
A	NULL
(	NULL
Figs	NULL
.	NULL

5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Nevertheless	NULL
,	NULL
fusion	NULL
of	NULL
normal	NULL
KJ1-26	NULL
``	NULL
T	NULL
cells	NULL
with	NULL
anergic	NULL
CFSE-stained	NULL
A.E7	NULL
or	NULL
16B.2	NULL
T	NULL
cells	NULL
yielded	NULL
a	NULL
population	NULL
of	NULL
CFSE*	NULL
KJ1-26+*	NULL
heterokaryons	NULL
that	NULL
was	NULL
deficient	NULL
in	NULL
the	NULL
production	NULL
of	NULL
IL-2	NULL
relative	NULL
to	NULL
either	NULL
normal	NULL
heterokaryons	NULL
or	NULL
unfused	NULL
T	NULL
cell	NULL
Anergic	NULL
Murine	NULL
Murine/Human	NULL
Heterokaryon	NULL
Jurkat	NULL
Human	NULL
T	NULL
cell	NULL
FIGURE	NULL
4	NULL
.	NULL

Models	NULL
of	NULL
T	NULL
cell	NULL
clonal	NULL
anergy	NULL
.	NULL

Results	NULL
obtained	NULL
here	NULL
argue	NULL
against	NULL
a	NULL
model	NULL
(	NULL
4	NULL
)	NULL
in	NULL
which	NULL
the	NULL
loss	NULL
of	NULL
a	NULL
signaling	NULL
component	NULL
in	NULL
anergic	NULL
cells	NULL
(	NULL
illustrated	NULL
by	NULL
the	NULL
lack	NULL
of	NULL
a	NULL
red	NULL
Y	NULL
molecule	NULL
)	NULL
interrupts	NULL
signal	NULL
transduction	NULL
to	NULL
the	NULL
murine	NULL
IL-2	NULL
gene	NULL
,	NULL
as	NULL
heterokaryon	NULL
formation	NULL
failed	NULL
to	NULL
overcome	NULL
the	NULL
clonal	NULL
anergy	NULL
defect	NULL
by	NULL
the	NULL
provision	NULL
of	NULL
normal	NULL
signaling	NULL
molecules	NULL
of	NULL
human	NULL
origin	NULL
(	NULL
denoted	NULL
by	NULL
the	NULL
blue	NULL
letters	NULL
marked	NULL
with	NULL
an	NULL
asterisk	NULL
)	NULL
.	NULL

Instead	NULL
,	NULL
the	NULL
data	NULL
are	NULL
most	NULL
consistent	NULL
with	NULL
a	NULL
model	NULL
(	NULL
B	NULL
)	NULL
in	NULL
which	NULL
signals	NULL
can	NULL
not	NULL
be	NULL
transduced	NULL
in	NULL
anergic	NULL
murine/human	NULL
heterokaryons	NULL
by	NULL
either	NULL
murine	NULL
(	NULL
red	NULL
letters	NULL
)	NULL
or	NULL
human	NULL
(	NULL
blue	NULL
letters	NULL
with	NULL
the	NULL
asterisk	NULL
)	NULL
signaling	NULL
components	NULL
because	NULL
of	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
dominant-acting	NULL
repressor	NULL
molecule	NULL
(	NULL
indicated	NULL
by	NULL
the	NULL
violet	NULL
shaded	NULL
starburst	NULL
)	NULL
.	NULL

Anerg	NULL
del	NULL
1	NULL
:	NULL
Depletion	NULL
of	NULL
signaling	NULL
molecule	NULL
Anergy	NULL
Model	NULL
2	NULL
:	NULL
Repression	NULL
of	NULL
signaling	NULL
cascade	NULL
6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
1464	NULL
No	NULL
A	NULL
Stimulation	NULL
lono/PMA	NULL
la	NULL
KJ1-26+	NULL
‘	NULL
$	NULL
3	NULL
?	NULL

“	NULL
Hetero-|	NULL
Lhe	NULL
£7	NULL
karyons	NULL
a	NULL
|	NULL
w	NULL
U	NULL
A	NULL
54	NULL
u	NULL
u	NULL
No	NULL
8	NULL
;	NULL
Stimulation	NULL
lono/PMA	NULL
R2	NULL
-	NULL
r	NULL
r	NULL
\	NULL
thl	NULL
log	NULL
FL3	NULL
(	NULL
KJ1-26	NULL
)	NULL
j	NULL
}	NULL
;	NULL
xy	NULL
KJ1-26+	NULL
u—jbf	NULL
}	NULL
T	NULL
cells	NULL
log	NULL
FL2	NULL
(	NULL
IL-2	NULL
)	NULL
-	NULL
log	NULL
FL2	NULL
(	NULL
IL-2	NULL
)	NULL
CD3/CD28	NULL
mAbs	NULL
lono/PMA	NULL
C	NULL
bane	NULL
§	NULL
.	NULL

``	NULL
,	NULL
``	NULL
``	NULL
pens	NULL
1000	NULL
1	NULL
p=.048	NULL
fax	NULL
00	NULL
-	NULL
m-	NULL
1-3	NULL
&	NULL
-	NULL
400	NULL
[	NULL
a	NULL
1	NULL
|	NULL
ayn	NULL
e	NULL
``	NULL
``	NULL
Tse	NULL
Eusion	NULL
Partner	NULL
siv	NULL
soo	NULL
I	NULL
L	NULL
=	NULL
sao	NULL
C	NULL
]	NULL
Normal	NULL
©	NULL
-0	NULL
3	NULL
&	NULL
ano	NULL
[	NULL
BJ	NULL
Anergic	NULL
-	NULL
%	NULL
®	NULL
po	NULL
,	NULL
250	NULL
e	NULL
E	NULL
a	NULL
-	NULL
*	NULL
9	NULL
:	NULL
KJ1-26+	NULL
KJ1-26+	NULL
KJ1-26+	NULL
KJ1-26	NULL
#	NULL
Heterokaryons	NULL
T	NULL
cells	NULL
Heterokaryons	NULL
T	NULL
cells	NULL
(	NULL
R1	NULL
gated	NULL
)	NULL
_	NULL
(	NULL
R2	NULL
gated	NULL
)	NULL
(	NULL
R1	NULL
gated	NULL
)	NULL
_	NULL
(	NULL
R2	NULL
gated	NULL
)	NULL
FIGURE	NULL
5	NULL
.	NULL

Intracellular	NULL
IL-2	NULL
accumulation	NULL
is	NULL
inhibited	NULL
following	NULL
the	NULL
fusion	NULL
of	NULL
anergic	NULL
cloned	NULL
murine	NULL
T	NULL
cells	NULL
to	NULL
normal	NULL
DO11.10	NULL
murine	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
.	NULL

Normal	NULL
and	NULL
anergic	NULL
groups	NULL
of	NULL
cloned	NULL
murine	NULL
T	NULL
cells	NULL
(	NULL
either	NULL
A.E7	NULL
or	NULL
16B.2	NULL
)	NULL
were	NULL
first	NULL
treated	NULL
with	NULL
CFSE	NULL
and	NULL
then	NULL
mixed	NULL
with	NULL
normal	NULL
DO11.10	NULL
CD4*	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PEG	NULL
.	NULL

Following	NULL
cell	NULL
fusion	NULL
,	NULL
cultures	NULL
were	NULL
stimulated	NULL
for	NULL
7	NULL
h	NULL
,	NULL
with	NULL
the	NULL
addition	NULL
of	NULL
brefeldin	NULL
A	NULL
during	NULL
the	NULL
final	NULL
5	NULL
h	NULL
of	NULL
the	NULL
cultivation	NULL
period	NULL
.	NULL

Cultures	NULL
were	NULL
then	NULL
harvested	NULL
,	NULL
and	NULL
murine/murine	NULL
heterokaryons	NULL
were	NULL
identified	NULL
by	NULL
flow	NULL
cytometry	NULL
using	NULL
the	NULL
fluorescence	NULL
of	NULL
CFSE	NULL
in	NULL
FL1	NULL
together	NULL
with	NULL
the	NULL
detection	NULL
of	NULL
the	NULL
DO11.10	NULL
Ag	NULL
receptor	NULL
with	NULL
KJ1-26-biotin	NULL
and	NULL
streptavidin-CyChrome	NULL
in	NULL
FL3	NULL
.	NULL

Double-positive	NULL
heterokaryons	NULL
and	NULL
single-positive	NULL
unfused	NULL
KJ1-26	NULL
*	NULL
T	NULL
cells	NULL
were	NULL
then	NULL
gated	NULL
electronically	NULL
(	NULL
RZ	NULL
and	NULL
R2	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
and	NULL
IL-2	NULL
accumulation	NULL
was	NULL
determined	NULL
in	NULL
each	NULL
subpopulation	NULL
in	NULL
response	NULL
to	NULL
stimuli	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
panels	NULL
.	NULL

A	NULL
,	NULL
Representative	NULL
example	NULL
of	NULL
murine/murine	NULL
heterokaryon	NULL
formation	NULL
and	NULL
normal	NULL
response	NULL
to	NULL
Iono/PMA	NULL
.	NULL

B	NULL
and	NULL
C	NULL
,	NULL
Average	NULL
intracellular	NULL
IL-2	NULL
accumulation	NULL
by	NULL
normal	NULL
(	NULL
open	NULL
bars	NULL
)	NULL
and	NULL
anergic	NULL
(	NULL
filled	NULL
bars	NULL
)	NULL
murine/	NULL
murine	NULL
heterokaryons	NULL
(	NULL
RZ	NULL
)	NULL
or	NULL
unfused	NULL
normal	NULL
KJ1-26	NULL
*	NULL
T	NULL
cells	NULL
(	NULL
R2	NULL
)	NULL
.	NULL

Cultures	NULL
were	NULL
stimulated	NULL
either	NULL
with	NULL
the	NULL
combination	NULL
of	NULL
CD3	NULL
plus	NULL
CD28	NULL
mAbs	NULL
(	NULL
B	NULL
)	NULL
or	NULL
with	NULL
Jono	NULL
plus	NULL
PMA	NULL
(	NULL
C	NULL
)	NULL
.	NULL

Data	NULL
in	NULL
B	NULL
and	NULL
C	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
for	NULL
replicate	NULL
experiments	NULL
,	NULL
and	NULL
values	NULL
shown	NULL
represent	NULL
the	NULL
product	NULL
:	NULL
geometric	NULL
mean	NULL
fluorescence	NULL
for	NULL
IL-2-positive	NULL
cells	NULL
X	NULL
percentage	NULL
of	NULL
IL-2-positive	NULL
cells	NULL
X	NULL
100	NULL
.	NULL

KJ1-26	NULL
*	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
stimulation	NULL
with	NULL
the	NULL
combination	NULL
of	NULL
CD3	NULL
and	NULL
CD28	NULL
mAbs	NULL
,	NULL
IL-2	NULL
production	NULL
by	NULL
anergic	NULL
murine/murine	NULL
heterokaryons	NULL
was	NULL
reduced	NULL
48	NULL
+	NULL
4	NULL
%	NULL
compared	NULL
with	NULL
that	NULL
by	NULL
control	NULL
heterokaryons	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
heterokaryons	NULL
,	NULL
IL-2	NULL
synthesis	NULL
by	NULL
the	NULL
majority	NULL
of	NULL
KJ1-26	NULL
``	NULL
T	NULL
cells	NULL
that	NULL
remained	NULL
unfused	NULL
in	NULL
the	NULL
PEG-treated	NULL
cultures	NULL
was	NULL
not	NULL
significantly	NULL
reduced	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
anergic	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
.	NULL

These	NULL
observations	NULL
of	NULL
a	NULL
dominant-acting	NULL
repressor	NULL
molecule	NULL
in	NULL
anergic	NULL
T	NULL
cells	NULL
are	NULL
consistent	NULL
with	NULL
previous	NULL
speculation	NULL
regarding	NULL
the	NULL
accumulation	NULL
of	NULL
a	NULL
putative	NULL
``	NULL
unresponsiveness	NULL
gene	NULL
``	NULL
product	NULL
capable	NULL
of	NULL
blocking	NULL
activation	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

Previously	NULL
,	NULL
it	NULL
was	NULL
reported	NULL
that	NULL
the	NULL
Src	NULL
family	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
p59Fyn	NULL
is	NULL
overexpressed	NULL
and	NULL
hyperactive	NULL
in	NULL
anergic	NULL
Th	NULL
cells	NULL
(	NULL
20-	NULL
MOLECULAR	NULL
REPRESSOR	NULL
IN	NULL
ANERGIC	NULL
T	NULL
HETEROKARYONS	NULL
22	NULL
)	NULL
.	NULL

Such	NULL
high	NULL
constitutive	NULL
kinase	NULL
activity	NULL
could	NULL
,	NULL
perhaps	NULL
,	NULL
desensitize	NULL
the	NULL
coupling	NULL
of	NULL
CD3	NULL
molecules	NULL
to	NULL
pathways	NULL
downstream	NULL
of	NULL
p21	NULL
``	NULL
``	NULL
in	NULL
anergic	NULL
T	NULL
cells	NULL
even	NULL
after	NULL
heterokaryon	NULL
formation	NULL
as	NULL
a	NULL
result	NULL
of	NULL
increased	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
functional	NULL
sequestration	NULL
of	NULL
the	NULL
adapter	NULL
protein	NULL
Cbl	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Likewise	NULL
,	NULL
the	NULL
constitutively	NULL
active	NULL
Rap1l	NULL
GTP-binding	NULL
protein	NULL
that	NULL
has	NULL
been	NULL
observed	NULL
in	NULL
anergic	NULL
cells	NULL
might	NULL
also	NULL
be	NULL
expected	NULL
to	NULL
act	NULL
as	NULL
a	NULL
repressor	NULL
molecule	NULL
as	NULL
a	NULL
result	NULL
of	NULL
its	NULL
ability	NULL
to	NULL
physically	NULL
sequester	NULL
Raf-1	NULL
kinase	NULL
in	NULL
an	NULL
inactive	NULL
state	NULL
,	NULL
as	NULL
suggested	NULL
by	NULL
Boussiotis	NULL
and	NULL
colleagues	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Overexpression	NULL
or	NULL
-activation	NULL
of	NULL
protein	NULL
tyrosine	NULL
phosphatases	NULL
such	NULL
as	NULL
Shp	NULL
or	NULL
Syp	NULL
might	NULL
also	NULL
be	NULL
expected	NULL
to	NULL
inhibit	NULL
signaling	NULL
downstream	NULL
to	NULL
p21	NULL
``	NULL
``	NULL
by	NULL
antagonizing	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
tyrosine	NULL
kinase	NULL
Zap70	NULL
or	NULL
promoting	NULL
the	NULL
activities	NULL
of	NULL
the	NULL
CTLA4-negative	NULL
regulatory	NULL
molecule	NULL
,	NULL
respectively	NULL
(	NULL
24	NULL
,	NULL
25	NULL
)	NULL
.	NULL

However	NULL
,	NULL
no	NULL
information	NULL
regarding	NULL
the	NULL
behavior	NULL
of	NULL
such	NULL
phosphatases	NULL
in	NULL
anergic	NULL
T	NULL
cells	NULL
has	NULL
yet	NULL
been	NULL
reported	NULL
.	NULL

Data	NULL
shown	NULL
here	NULL
now	NULL
document	NULL
the	NULL
actions	NULL
of	NULL
a	NULL
repressor	NULL
molecule	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
endogenous	NULL
IL-2	NULL
gene	NULL
expression	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
in	NULL
these	NULL
experiments	NULL
the	NULL
actions	NULL
of	NULL
such	NULL
a	NULL
repressor	NULL
molecule	NULL
would	NULL
dominate	NULL
over	NULL
the	NULL
complementation	NULL
of	NULL
a	NULL
missing	NULL
signaling	NULL
component	NULL
,	NULL
should	NULL
both	NULL
have	NULL
occurred	NULL
in	NULL
heterokaryons	NULL
of	NULL
anergic	NULL
T	NULL
cells	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
both	NULL
a	NULL
repressive	NULL
mechanism	NULL
and	NULL
the	NULL
loss	NULL
of	NULL
a	NULL
signaling	NULL
component	NULL
coexist	NULL
in	NULL
anergic	NULL
T	NULL
cells	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
observation	NULL
of	NULL
a	NULL
dominant-acting	NULL
repression	NULL
does	NULL
not	NULL
allow	NULL
for	NULL
a	NULL
determination	NULL
of	NULL
the	NULL
location	NULL
of	NULL
the	NULL
repressor	NULL
molecule	NULL
(	NULL
s	NULL
)	NULL
within	NULL
anergic	NULL
T	NULL
cells	NULL
.	NULL

Previous	NULL
biochemical	NULL
analyses	NULL
of	NULL
anergic	NULL
murine	NULL
Th	NULL
cells	NULL
have	NULL
indicated	NULL
a	NULL
block	NULL
in	NULL
signal	NULL
transduction	NULL
to	NULL
p21	NULL
``	NULL
``	NULL
and	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
kinases	NULL
(	NULL
MAPK	NULL
)	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
,	NULL
resulting	NULL
in	NULL
poor	NULL
induction	NULL
of	NULL
Fos	NULL
and	NULL
Jun	NULL
species	NULL
important	NULL
to	NULL
frans-activation	NULL
at	NULL
the	NULL
5	NULL
'	NULL
IL-2	NULL
gene	NULL
enhancer	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
these	NULL
new	NULL
results	NULL
could	NULL
support	NULL
a	NULL
model	NULL
in	NULL
which	NULL
a	NULL
proximal	NULL
inhibitor	NULL
molecule	NULL
blocks	NULL
the	NULL
coupling	NULL
of	NULL
the	NULL
Ag	NULL
receptor	NULL
to	NULL
p21	NULL
``	NULL
.	NULL

Nevertheless	NULL
,	NULL
these	NULL
data	NULL
may	NULL
also	NULL
have	NULL
resulted	NULL
from	NULL
the	NULL
effects	NULL
of	NULL
a	NULL
nuclear	NULL
repressor	NULL
molecule	NULL
capable	NULL
of	NULL
trans-locating	NULL
to	NULL
the	NULL
heterokaryon	NULL
's	NULL
normal	NULL
nucleus	NULL
during	NULL
the	NULL
course	NULL
of	NULL
the	NULL
experiment	NULL
.	NULL

The	NULL
zinc	NULL
finger	NULL
DNA	NULL
binding	NULL
protein	NULL
called	NULL
negative	NULL
regulator	NULL
of	NULL
IL-2a	NULL
(	NULL
Nil-2a	NULL
)	NULL
has	NULL
the	NULL
capacity	NULL
to	NULL
inhibit	NULL
transactivation	NULL
at	NULL
the	NULL
IL-2	NULL
gene	NULL
(	NULL
26	NULL
)	NULL
,	NULL
and	NULL
overexpression	NULL
of	NULL
this	NULL
repressor	NULL
molecule	NULL
has	NULL
previously	NULL
been	NULL
suggested	NULL
as	NULL
the	NULL
basis	NULL
for	NULL
clonal	NULL
anergy	NULL
in	NULL
human	NULL
T	NULL
cell	NULL
clones	NULL
(	NULL
27	NULL
)	NULL
.	NULL

A	NULL
pair	NULL
of	NULL
activating	NULL
protein-1-like	NULL
DNA	NULL
sequences	NULL
within	NULL
the	NULL
5	NULL
'	NULL
ZL-2	NULL
gene	NULL
enhancer	NULL
have	NULL
also	NULL
been	NULL
suggested	NULL
as	NULL
the	NULL
targets	NULL
of	NULL
dominant	NULL
negative	NULL
regulation	NULL
in	NULL
the	NULL
nucleus	NULL
of	NULL
anergic	NULL
murine	NULL
T	NULL
cells	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Iono	NULL
plus	NULL
PMA	NULL
activation	NULL
can	NULL
not	NULL
bypass	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
anergy	NULL
repressor	NULL
molecule	NULL
Previously	NULL
,	NULL
we	NULL
reported	NULL
that	NULL
the	NULL
stimulation	NULL
of	NULL
anergic	NULL
T	NULL
cells	NULL
with	NULL
the	NULL
combination	NULL
of	NULL
a	NULL
calcium	NULL
ionophore	NULL
and	NULL
protein	NULL
kinase	NULL
C-activating	NULL
phorbol	NULL
ester	NULL
resulted	NULL
in	NULL
a	NULL
significant	NULL
,	NULL
albeit	NULL
incomplete	NULL
,	NULL
restoration	NULL
of	NULL
their	NULL
proliferative	NULL
capacity	NULL
(	NULL
5	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
had	NULL
demonstrated	NULL
an	NULL
ability	NULL
of	NULL
PMA	NULL
to	NULL
bypass	NULL
the	NULL
defect	NULL
in	NULL
anergic	NULL
cells	NULL
that	NULL
otherwise	NULL
resulted	NULL
in	NULL
an	NULL
inability	NULL
to	NULL
activate	NULL
MAPK	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
was	NULL
of	NULL
interest	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
repressor	NULL
molecule	NULL
acting	NULL
in	NULL
anergic	NULL
murine/murine	NULL
heterokaryons	NULL
had	NULL
any	NULL
capacity	NULL
to	NULL
interfere	NULL
with	NULL
IL-2	NULL
protein	NULL
accumulation	NULL
in	NULL
response	NULL
to	NULL
treatment	NULL
with	NULL
Iono/PMA	NULL
.	NULL

If	NULL
true	NULL
,	NULL
this	NULL
would	NULL
indicate	NULL
that	NULL
the	NULL
repressor	NULL
molecule	NULL
acts	NULL
downstream	NULL
of	NULL
the	NULL
MAPK	NULL
or	NULL
in	NULL
a	NULL
separate	NULL
signaling	NULL
pathway	NULL
parallel	NULL
to	NULL
the	NULL
MAPK	NULL
cascade	NULL
.	NULL

IL-2	NULL
production	NULL
in	NULL
anergic	NULL
murine/murine	NULL
heterokaryons	NULL
was	NULL
,	NULL
in	NULL
fact	NULL
,	NULL
observed	NULL
to	NULL
be	NULL
defective	NULL
following	NULL
incubation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
Iono	NULL
and	NULL
PMA	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

Anergic	NULL
murine/murine	NULL
heterokaryons	NULL
activated	NULL
with	NULL
Iono/PMA	NULL
again	NULL
demonstrated	NULL
a	NULL
48	NULL
+	NULL
5	NULL
%	NULL
reduction	NULL
in	NULL
IL-2	NULL
production	NULL
relative	NULL
to	NULL
that	NULL
by	NULL
control	NULL
heterokaryons	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
Normal	NULL
Anergic	NULL
A	NULL
B	NULL
g	NULL
4	NULL
g	NULL
1	NULL
2.4	NULL
%	NULL
.1	NULL
%	NULL
3	NULL
3	NULL
z	NULL
i	NULL
\	NULL
l	NULL
CD3/CD28	NULL
3	NULL
4	NULL
2m	NULL
.	NULL

a	NULL
i	NULL
\	NULL
mAbs	NULL
¢	NULL
\A	NULL
,	NULL
NAM	NULL
“	NULL
—	NULL
3	NULL
rj	NULL
C	NULL
D	NULL
§	NULL
as.renes	NULL
|	NULL
$	NULL
4	NULL
\	NULL
18.421	NULL
%	NULL
§	NULL
f	NULL
2	NULL
i	NULL
lono/PMA	NULL
log	NULL
FL2	NULL
(	NULL
IL-2	NULL
)	NULL
log	NULL
FL2	NULL
(	NULL
IL-2	NULL
)	NULL
FIGURE	NULL
6	NULL
.	NULL

-	NULL
Tono	NULL
and	NULL
PMA	NULL
stimulation	NULL
of	NULL
anergic	NULL
DO11.10	NULL
T	NULL
cells	NULL
only	NULL
partially	NULL
overcomes	NULL
the	NULL
defect	NULL
in	NULL
intracellular	NULL
IL-2	NULL
accumulation	NULL
.	NULL

Normal	NULL
control	NULL
(	NULL
A	NULL
and	NULL
C	NULL
)	NULL
and	NULL
anergic	NULL
(	NULL
B	NULL
and	NULL
D	NULL
)	NULL
DO11.10	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
7	NULL
h	NULL
either	NULL
with	NULL
the	NULL
combination	NULL
of	NULL
CD3	NULL
and	NULL
CD28	NULL
mAbs	NULL
(	NULL
immobilized	NULL
at	NULL
0.5	NULL
and	NULL
10	NULL
ug/ml	NULL
,	NULL
respectively	NULL
;	NULL
A	NULL
and	NULL
B	NULL
)	NULL
or	NULL
with	NULL
Iono	NULL
plus	NULL
PMA	NULL
(	NULL
C	NULL
and	NULL
D	NULL
)	NULL
,	NULL
with	NULL
brefeldin	NULL
A	NULL
added	NULL
during	NULL
the	NULL
final	NULL
5	NULL
h	NULL
of	NULL
culture	NULL
.	NULL

The	NULL
accumulation	NULL
of	NULL
intracellular	NULL
IL-2	NULL
protein	NULL
was	NULL
detected	NULL
in	NULL
T	NULL
cells	NULL
by	NULL
flow	NULL
cytometry	NULL
using	NULL
anti-IL-2-PE	NULL
(	NULL
dark	NULL
tracing	NULL
)	NULL
and	NULL
compared	NULL
with	NULL
staining	NULL
with	NULL
a	NULL
phy-coerythrin-conjugated	NULL
isotype-matched	NULL
Ab	NULL
as	NULL
a	NULL
control	NULL
(	NULL
light	NULL
tracing	NULL
)	NULL
.	NULL

Values	NULL
above	NULL
the	NULL
markers	NULL
indicate	NULL
the	NULL
mean	NULL
percentage	NULL
of	NULL
IL-2-positive	NULL
cells	NULL
within	NULL
the	NULL
indicated	NULL
region	NULL
+	NULL
SEM	NULL
for	NULL
replicate	NULL
samples	NULL
.	NULL

Unstimulated	NULL
T	NULL
cells	NULL
were	NULL
,	NULL
on	NULL
the	NULL
average	NULL
,	NULL
3.0	NULL
+	NULL
0.3	NULL
%	NULL
IL-2	NULL
positive	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
observed	NULL
with	NULL
the	NULL
16B.2	NULL
T	NULL
cell	NULL
clone	NULL
.	NULL

The	NULL
finding	NULL
that	NULL
anergic	NULL
heterokaryons	NULL
remain	NULL
defective	NULL
for	NULL
IL-2	NULL
synthesis	NULL
even	NULL
after	NULL
stimulation	NULL
with	NULL
the	NULL
combination	NULL
of	NULL
a	NULL
calcium	NULL
ionophore	NULL
and	NULL
protein	NULL
kinase	NULL
C-activating	NULL
phorbol	NULL
ester	NULL
suggests	NULL
that	NULL
clonal	NULL
anergy	NULL
does	NULL
not	NULL
act	NULL
solely	NULL
to	NULL
interfere	NULL
with	NULL
signals	NULL
upstream	NULL
of	NULL
ERK	NULL
and	NULL
JNK	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
intracellular	NULL
IL-2	NULL
accumulation	NULL
by	NULL
anergic	NULL
DO11.10	NULL
T	NULL
cells	NULL
was	NULL
only	NULL
partially	NULL
restored	NULL
during	NULL
stimulation	NULL
with	NULL
Iono/PMA	NULL
(	NULL
38	NULL
%	NULL
of	NULL
the	NULL
normal	NULL
control	NULL
T	NULL
cell	NULL
response	NULL
vs	NULL
a	NULL
response	NULL
that	NULL
was	NULL
7	NULL
%	NULL
of	NULL
the	NULL
control	NULL
following	NULL
stimulation	NULL
with	NULL
CD3/CD28	NULL
mAbs	NULL
;	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
now	NULL
suggest	NULL
a	NULL
model	NULL
in	NULL
which	NULL
clonal	NULL
anergy	NULL
induction	NULL
both	NULL
interferes	NULL
with	NULL
the	NULL
upstream	NULL
activation	NULL
of	NULL
p21	NULL
``	NULL
and	NULL
the	NULL
MAPK	NULL
and	NULL
represses	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
at	NULL
a	NULL
point	NULL
either	NULL
downstream	NULL
of	NULL
or	NULL
parallel	NULL
to	NULL
the	NULL
MAPK	NULL
.	NULL

Thus	NULL
,	NULL
a	NULL
biochemical	NULL
examination	NULL
of	NULL
signal	NULL
transduction	NULL
events	NULL
in	NULL
anergic	NULL
heterokaryons	NULL
will	NULL
be	NULL
necessary	NULL
to	NULL
determine	NULL
whether	NULL
this	NULL
negative	NULL
regulator	NULL
is	NULL
also	NULL
acting	NULL
to	NULL
block	NULL
signal	NULL
transduction	NULL
upstream	NULL
of	NULL
p21	NULL
``	NULL
``	NULL
or	NULL
whether	NULL
complementation	NULL
of	NULL
a	NULL
proximal	NULL
defect	NULL
did	NULL
,	NULL
in	NULL
fact	NULL
,	NULL
occur	NULL
in	NULL
the	NULL
setting	NULL
of	NULL
a	NULL
coexisting	NULL
molecular	NULL
repressor	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
L.	NULL
Davis	NULL
for	NULL
early	NULL
discussions	NULL
regarding	NULL
the	NULL
feasibility	NULL
of	NULL
this	NULL
study	NULL
.	NULL

We	NULL
also	NULL
appreciate	NULL
the	NULL
valuable	NULL
RT-PCR	NULL
technical	NULL
advice	NULL
provided	NULL
by	NULL
T.	NULL
Behrens	NULL
,	NULL
help	NULL
with	NULL
confocal	NULL
microscopy	NULL
provided	NULL
by	NULL
E.	NULL
Ingulli	NULL
,	NULL
and	NULL
the	NULL
expertise	NULL
of	NULL
K.	NULL
Pape	NULL
and	NULL
A.	NULL
Khoruts	NULL
in	NULL
the	NULL
development	NULL
of	NULL
the	NULL
cyto-plasmic	NULL
IL-2	NULL
staining	NULL
system	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
thank	NULL
T.	NULL
LeBien	NULL
and	NULL
B	NULL
.	NULL

Van	NULL
Ness	NULL
for	NULL
critically	NULL
reviewing	NULL
the	NULL
manuscript	NULL
,	NULL
and	NULL
M.	NULL
Jenkins	NULL
for	NULL
his	NULL
continuing	NULL
support	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Jenkins	NULL
,	NULL
M.	NULL
K.	NULL
,	NULL
and	NULL
R.	NULL
H.	NULL
Schwartz	NULL
.	NULL

1987	NULL
.	NULL

Antigen	NULL
presentation	NULL
by	NULL
chemically	NULL
modified	NULL
splenocytes	NULL
induces	NULL
antigen-specific	NULL
T	NULL
cell	NULL
unresponsiveness	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

165:302	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

1465	NULL
.	NULL

Jenkins	NULL
,	NULL
M.	NULL
K.	NULL
,	NULL
D.	NULL
M.	NULL
Pardoll	NULL
,	NULL
J.	NULL
Mizuguchi	NULL
,	NULL
T.	NULL
M.	NULL
Chused	NULL
,	NULL
and	NULL
R.	NULL
H.	NULL
Schwartz	NULL
.	NULL

1987	NULL
.	NULL

Molecular	NULL
events	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
a	NULL
nonresponsive	NULL
state	NULL
in	NULL
interleukin	NULL
2-producing	NULL
helper	NULL
T-lymphocyte	NULL
clones	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84:5409.	NULL
.	NULL

Harding	NULL
,	NULL
F.	NULL
A.	NULL
,	NULL
J.	NULL
G.	NULL
McArthur	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

Gross	NULL
,	NULL
D.	NULL
H.	NULL
Raulet	NULL
,	NULL
and	NULL
J.	NULL
P.	NULL
Allison	NULL
.	NULL

1992	NULL
.	NULL

CD28-mediated	NULL
signalling	NULL
co-stimulates	NULL
murine	NULL
T	NULL
cells	NULL
and	NULL
prevents	NULL
induction	NULL
of	NULL
anergy	NULL
in	NULL
T-cell	NULL
clones	NULL
.	NULL

Nature	NULL
356:607.	NULL
.	NULL

Mueller	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
and	NULL
M.	NULL
K.	NULL
Jenkins	NULL
.	NULL

1995	NULL
.	NULL

Molecular	NULL
mechanisms	NULL
underlying	NULL
functional	NULL
T-cell	NULL
unresponsiveness	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

7:375.	NULL
.	NULL

Li	NULL
,	NULL
W.	NULL
,	NULL
C.	NULL
D.	NULL
Whaley	NULL
,	NULL
A.	NULL
Mondino	NULL
,	NULL
and	NULL
D.	NULL
L.	NULL
Mueller	NULL
.	NULL

1996	NULL
.	NULL

Blocked	NULL
signal	NULL
transduction	NULL
to	NULL
the	NULL
ERK	NULL
and	NULL
JNK	NULL
protein	NULL
kinases	NULL
in	NULL
anergic	NULL
CD4*	NULL
T	NULL
cells	NULL
.	NULL

Science	NULL
271:1272.	NULL
.	NULL

Fields	NULL
,	NULL
P.	NULL
E.	NULL
,	NULL
T.	NULL
F.	NULL
Gajewski	NULL
,	NULL
and	NULL
F.	NULL
W.	NULL
Fitch	NULL
.	NULL

1996	NULL
.	NULL

Blocked	NULL
Ras	NULL
activation	NULL
in	NULL
anergic	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
.	NULL

Science	NULL
271:1276.	NULL
.	NULL

Kang	NULL
,	NULL
S.-M.	NULL
,	NULL
B.	NULL
Beverly	NULL
,	NULL
A.C.	NULL
Tran	NULL
,	NULL
K.	NULL
Brorson	NULL
,	NULL
R.	NULL
H.	NULL
Schwartz	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Lenardo	NULL
.	NULL

1992	NULL
.	NULL

Transactivation	NULL
by	NULL
AP-1	NULL
is	NULL
a	NULL
molecular	NULL
target	NULL
of	NULL
T	NULL
cell	NULL
clonal	NULL
anergy	NULL
.	NULL

Science	NULL
257:1134.	NULL
.	NULL

Mondino	NULL
,	NULL
A.	NULL
,	NULL
C.	NULL
D.	NULL
Whaley	NULL
,	NULL
D.	NULL
R.	NULL
DeSilva	NULL
,	NULL
W.	NULL
Li	NULL
,	NULL
M.	NULL
K.	NULL
Jenkins	NULL
,	NULL
and	NULL
D.	NULL
L.	NULL
Mueller	NULL
.	NULL

1996	NULL
.	NULL

Defective	NULL
transcription	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
is	NULL
associated	NULL
with	NULL
impaired	NULL
expression	NULL
of	NULL
c-Fos	NULL
,	NULL
FosB	NULL
,	NULL
and	NULL
JunB	NULL
in	NULL
anergic	NULL
T	NULL
helper	NULL
1	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157:2048.	NULL
.	NULL

Sundstedt	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
Sigvardsson	NULL
,	NULL
T.	NULL
Leanderson	NULL
,	NULL
G.	NULL
Hedlund	NULL
,	NULL
T.	NULL
Kalland	NULL
,	NULL
and	NULL
M.	NULL
Dohlsten	NULL
.	NULL

1996	NULL
.	NULL

In	NULL
vivo	NULL
anergized	NULL
CD4*	NULL
T	NULL
cells	NULL
express	NULL
perturbed	NULL
AP-1	NULL
and	NULL
NF-KB	NULL
transcription	NULL
factors	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93:979	NULL
.	NULL

Hecht	NULL
,	NULL
T.	NULL
T.	NULL
,	NULL
D.	NULL
L.	NULL
Longo	NULL
,	NULL
and	NULL
L.	NULL
A.	NULL
Matis	NULL
.	NULL

1983	NULL
.	NULL

The	NULL
relationship	NULL
between	NULL
immune	NULL
interferon	NULL
production	NULL
and	NULL
proliferation	NULL
in	NULL
antigen-specific	NULL
,	NULL
MHC-re-stricted	NULL
T	NULL
cell	NULL
lines	NULL
and	NULL
clones	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

131:1049	NULL
.	NULL

Mueller	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
L.	NULL
Chiodetti	NULL
,	NULL
P.	NULL
A.	NULL
Bacon	NULL
,	NULL
and	NULL
R.	NULL
H.	NULL
Schwartz	NULL
.	NULL

1991	NULL
.	NULL

Clonal	NULL
anergy	NULL
blocks	NULL
the	NULL
response	NULL
to	NULL
IL-4	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
production	NULL
of	NULL
IL-2	NULL
,	NULL
in	NULL
dual-producing	NULL
T	NULL
helper	NULL
cell	NULL
clones	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

147:4118	NULL
.	NULL

Murphy	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Heimberger	NULL
,	NULL
and	NULL
D.	NULL
Y.	NULL
Loh	NULL
.	NULL

1990	NULL
.	NULL

Induction	NULL
by	NULL
antigen	NULL
of	NULL
intrathymic	NULL
apoptosis	NULL
of	NULL
CD4*	NULL
CD8*	NULL
TCR	NULL
``	NULL
thymocytes	NULL
in	NULL
vivo	NULL
.	NULL

Science	NULL
250	NULL
:	NULL
1720	NULL
.	NULL

Haskins	NULL
,	NULL
K.	NULL
,	NULL
R.	NULL
Kubo	NULL
,	NULL
J	NULL
.	NULL

White	NULL
,	NULL
M.	NULL
Pigeon	NULL
,	NULL
J.	NULL
Kappler	NULL
,	NULL
and	NULL
P.	NULL
Marrack	NULL
.	NULL

1983	NULL
.	NULL

The	NULL
major	NULL
histocompatibility	NULL
complex-restricted	NULL
antigen	NULL
receptor	NULL
on	NULL
T	NULL
cells	NULL
.	NULL

I	NULL
.	NULL

Isolation	NULL
with	NULL
a	NULL
monoclonal	NULL
antibody	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

157:1149	NULL
.	NULL

Baron	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1986	NULL
.	NULL

Rapid	NULL
reprogramming	NULL
of	NULL
globin	NULL
gene	NULL
expression	NULL
in	NULL
transient	NULL
heterokaryons	NULL
.	NULL

Cell	NULL
46:591	NULL
.	NULL

Leo	NULL
,	NULL
O.	NULL
,	NULL
M.	NULL
Foo	NULL
,	NULL
D.	NULL
H.	NULL
Sachs	NULL
,	NULL
L.	NULL
E.	NULL
Samelson	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Bluestone	NULL
.	NULL

1987	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
monoclonal	NULL
antibody	NULL
specific	NULL
for	NULL
a	NULL
murine	NULL
T3	NULL
polypeptide	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84:1374	NULL
.	NULL

Malvey	NULL
,	NULL
E.-N.	NULL
,	NULL
M.	NULL
K.	NULL
Jenkins	NULL
,	NULL
and	NULL
D.	NULL
L.	NULL
Mueller	NULL
.	NULL

1998	NULL
.	NULL

Peripheral	NULL
immune	NULL
tolerance	NULL
blocks	NULL
clonal	NULL
expansion	NULL
,	NULL
but	NULL
fails	NULL
to	NULL
prevent	NULL
the	NULL
differentiation	NULL
of	NULL
Th1	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:2168	NULL
.	NULL

Hautamaa	NULL
,	NULL
D.	NULL
,	NULL
R.	NULL
Merica	NULL
,	NULL
Z.	NULL
Chen	NULL
,	NULL
and	NULL
M.	NULL
K.	NULL
Jenkins	NULL
.	NULL

1997	NULL
.	NULL

Murine	NULL
lymphotactin	NULL
:	NULL
gene	NULL
structure	NULL
,	NULL
post-translational	NULL
modification	NULL
and	NULL
inhibition	NULL
of	NULL
expression	NULL
by	NULL
CD28	NULL
costimulation	NULL
.	NULL

Cytokine	NULL
9:375	NULL
.	NULL

Mueller	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
M.	NULL
K.	NULL
Jenkins	NULL
,	NULL
and	NULL
R.	NULL
H.	NULL
Schwartz	NULL
.	NULL

1989	NULL
.	NULL

Clonal	NULL
expansion	NULL
versus	NULL
functional	NULL
clonal	NULL
inactivation	NULL
:	NULL
a	NULL
costimulatory	NULL
signalling	NULL
pathway	NULL
determines	NULL
the	NULL
outcome	NULL
of	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
occupancy	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

7:445	NULL
.	NULL

Jenkins	NULL
,	NULL
M.	NULL
K.	NULL
1992	NULL
.	NULL

Models	NULL
of	NULL
lymphocyte	NULL
activation	NULL
:	NULL
the	NULL
role	NULL
of	NULL
cell	NULL
division	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
clonal	NULL
anergy	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
13:69	NULL
.	NULL

Quill	NULL
,	NULL
H.	NULL
,	NULL
M.	NULL
P.	NULL
Riley	NULL
,	NULL
E.	NULL
A.	NULL
Cho	NULL
,	NULL
J.	NULL
E.	NULL
Casnellie	NULL
,	NULL
J.	NULL
C.	NULL
Reed	NULL
,	NULL
and	NULL
T.	NULL
Torigoe	NULL
.	NULL

1992	NULL
.	NULL

Anergic	NULL
Th1	NULL
cells	NULL
express	NULL
altered	NULL
levels	NULL
of	NULL
the	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
p356**	NULL
and	NULL
p59°	NULL
``	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

149:2887	NULL
.	NULL

Cho	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
M.	NULL
P.	NULL
Riley	NULL
,	NULL
A.	NULL
L.	NULL
Sillman	NULL
,	NULL
and	NULL
H.	NULL
Quill	NULL
.	NULL

1993	NULL
.	NULL

Altered	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
anergic	NULL
Th1	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

151:20.	NULL
.	NULL

Gajewski	NULL
,	NULL
T.	NULL
F.	NULL
,	NULL
D.	NULL
Qian	NULL
,	NULL
P.	NULL
Fields	NULL
,	NULL
and	NULL
F.	NULL
W.	NULL
Fitch	NULL
.	NULL

1994	NULL
.	NULL

Anergic	NULL
T-lymphocyte	NULL
clones	NULL
have	NULL
altered	NULL
inositol	NULL
phosphate	NULL
,	NULL
calcium	NULL
,	NULL
and	NULL
tyrosine	NULL
kinase	NULL
signaling	NULL
pathways	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:38	NULL
.	NULL

Boussiotis	NULL
,	NULL
V.	NULL
A.	NULL
,	NULL
G.	NULL
J.	NULL
Freeman	NULL
,	NULL
A.	NULL
Berezovskaya	NULL
,	NULL
D.	NULL
L.	NULL
Barber	NULL
,	NULL
and	NULL
L.	NULL
M.	NULL
Nadler	NULL
.	NULL

1997	NULL
.	NULL

Maintenance	NULL
of	NULL
human	NULL
T	NULL
cell	NULL
anergy	NULL
:	NULL
blocking	NULL
of	NULL
IL-2	NULL
gene	NULL
transcription	NULL
by	NULL
activated	NULL
Rap1	NULL
.	NULL

Science	NULL
278:124	NULL
.	NULL

Plas	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
R.	NULL
Johnson	NULL
,	NULL
J.	NULL
T.	NULL
Pingel	NULL
,	NULL
R.	NULL
J.	NULL
Matthews	NULL
,	NULL
M.	NULL
Dalton	NULL
,	NULL
G.	NULL
Roy	NULL
,	NULL
A.	NULL
C.	NULL
Chan	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Thomas	NULL
.	NULL

1996	NULL
.	NULL

Direct	NULL
regulation	NULL
of	NULL
ZAP-70	NULL
by	NULL
SHP-1	NULL
in	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
signaling	NULL
.	NULL

Science	NULL
272:1173	NULL
.	NULL

Marengere	NULL
,	NULL
L.	NULL
E.	NULL
,	NULL
P.	NULL
Waterhouse	NULL
,	NULL
G.	NULL
S.	NULL
Duncan	NULL
,	NULL
H.	NULL
W.	NULL
Mittrucker	NULL
,	NULL
G.	NULL
S.	NULL
Feng	NULL
,	NULL
and	NULL
T.	NULL
W.	NULL
Mak	NULL
.	NULL

1996	NULL
.	NULL

Regulation	NULL
of	NULL
T	NULL
cell	NULL
receptor	NULL
signaling	NULL
by	NULL
tyrosine	NULL
phos-phatase	NULL
SYP	NULL
association	NULL
with	NULL
CTLA-4	NULL
.	NULL

Science	NULL
272:1170	NULL
.	NULL

Williams	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
D.	NULL
Moolten	NULL
,	NULL
J.	NULL
Burlein	NULL
,	NULL
J.	NULL
Romano	NULL
,	NULL
R.	NULL
Bhaerman	NULL
,	NULL
A.	NULL
Godillot	NULL
,	NULL
M.	NULL
Mellon	NULL
,	NULL
F.	NULL
J.	NULL
Rauscher	NULL
III	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Kant	NULL
.	NULL

1994	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
zinc	NULL
finger	NULL
protein	NULL
that	NULL
inhibits	NULL
IL-2	NULL
gene	NULL
expression	NULL
.	NULL

Science	NULL
254:1791	NULL
.	NULL

Becker	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
T.	NULL
Brabletz	NULL
,	NULL
T.	NULL
Kirchner	NULL
,	NULL
C.	NULL
T.	NULL
Conrad	NULL
,	NULL
E.	NULL
B.	NULL
Brocker	NULL
,	NULL
and	NULL
R.	NULL
A.	NULL
Reisfeld	NULL
.	NULL

1995	NULL
.	NULL

Negative	NULL
transcriptional	NULL
regulation	NULL
in	NULL
anergic	NULL
T	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:2375	NULL
.	NULL

Kitagawa-Sakakida	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
R.	NULL
H.	NULL
Schwartz	NULL
.	NULL

1996	NULL
.	NULL

Multifactor	NULL
cis-dominant	NULL
negative	NULL
regulation	NULL
of	NULL
IL-2	NULL
gene	NULL
expression	NULL
in	NULL
anergized	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157	NULL
;	NULL
2328	NULL
.	NULL

6107	NULL
'01	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
jountwrut	NULL
{	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
;	NULL

